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Osteoarthritis (OA) is a degenerative disease. Currently, there are no 
treatments to restore damaged cartilage to its native state. Joint injury increases the 
risk of developing post-traumatic OA (PTOA). Subtle cartilage injury that may 
progress to PTOA cannot be detected with current clinical imaging modalities. If 
subtle cartilage injury is detectable, PTOA can be better understood to develop 
treatments targeting early disease progression. The goal of this dissertation was to 
evaluate methods for detecting, characterizing, and treating early cartilage injury. 
 Multiphoton microscopy (MPM) can provide high resolution details of live, 
intact tissue. The purpose of the first study was to validate the use of MPM to detect 
subtle cartilage damage. The results confirmed the ability of MPM to resolve 
structural changes and cell death in cartilage immediately after injury. This suggests 
future application of MPM in the clinic for early diagnosis or in the laboratory to 
perform longitudinal studies not currently possible due to the necessity of histological 
processing. 
 In the second study, cartilage and its resiliency to injury were evaluated among 
eight major joints to determine if there are different susceptibilities to injury in 
different joints. The structure of articular cartilage and prevalence of OA vary among 
joints, but typically results from work performed within a single joint are applied to 
other joints. The results from the second study showed that some joints have more 
 cellular death and/or decrease anabolic gene expression than other joints after 
receiving the same injury, which suggests the need for joint specific treatments. 
 The third study examined the role of oxygen in the development of PTOA. 
Cartilage is avascular and has limited oxygen supply. Oxygen tension may be 
increased in arthritic joints, yet short exposure to high oxygen tension is beneficial to 
uninjured cartilage. In this final study, the effect of increased oxygen tension on 
cartilage viability after injury was evaluated. The immediate application of hyperoxic 
treatment minimized cell death after injury, suggesting that the immediate application 
of high oxygen following injury may be chondroprotective. These findings have 
implications in future treatments that could minimize the effect of cartilage injury and 
development of PTOA. 
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CHAPTER 1 
INTRODUCTION 
 
Osteoarthritis and motivation for cartilage research 
Osteoarthritis (OA) is a progressive and degenerative disease that is becoming more 
prevalent with an increased aging population in the world.1,2 The etiology of OA is not 
fully understood and has numerous contributing factors including biomechanical, 
biochemical, genetic, and nutritional influences.1,3 However, the initiation of OA 
begins before clinical signs are observed. Cartilage injury that occurs during 
adolescence can develop into OA later in life. Cartilage damage, if left undiagnosed 
and untreated, can silently progress into post-traumatic OA (PTOA), in which clinical 
signs may not become evident for many years.4 In order to attenuate this natural 
disease progression, damage needs to, at minimum, be detected at the early, pre-
symptomatic stage of OA. After the disease has become symptomatic and severe, only 
treatments directed toward symptom management can be applied. Yet, at the early 
phase, therapeutic or rehabilitative methods could be administered to minimize the 
progression of OA. However, current clinical imaging techniques are limited in their 
resolution and may underdiagnose small focal regions of cartilage damage.5,6 With 
improved detection of cartilage damage, diseased cartilage can be identified earlier, 
which will strengthen the knowledge of the pathogenesis of PTOA and facilitate the 
development of new OA treatments. 
 Cell death occurs immediately after injury,7,8 and the importance of 
understanding how injury and cell death may lead to the progression of PTOA is 
becoming more apparent.9 In this dissertation research, high resolution imaging was 
used to help characterize the changes within equine or bovine cartilage immediately 
after injury. Using equine and bovine injury models can help improve understanding 
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in human OA because both animals have naturally-occurring OA that is similar to that 
found in humans. Multiphoton and confocal microscopy were used to identify cell 
death and the distribution of cells and cell death. Cell death along matrix cracks was 
quantified. This concept was further examined because cells adjacent to the cracks 
may be exposed to higher concentrations of oxygen post-injury than pre-injury. 
Oxygen exposure can affect the magnitude of cell death after injury.  
The overall motivation for the dissertation research was to identify a 
microscopic technique to identify early, subclinical cartilage damage ex vivo that 
could be applied clinically to expand the understanding of cartilage trauma. The 
hypothesis for the dissertation was that the use of high resolution microscopy imaging 
would identify differences in cartilage damage within joints, between joints, and 
between high and low oxygen exposure after traumatic injury. 
  
Post-traumatic osteoarthritis and early cartilage disease 
Trauma or repetitive injurious activity can result in permanent damage to cartilage.7,8 
With time, trauma-related damage may play a role and increase the risk in the 
progression of cartilage degeneration, eventually resulting in PTOA. In a 36 year long 
study following young adults (mean age at enrollment=22 years), there was increased 
association in the development of PTOA by the age of 65 with individuals who 
reported experiencing a knee injury prior to enrollment (13.9%) over those who did 
not (6.0%).4 This suggests that experiencing a joint injury early in life may increase 
the risk of developing PTOA with age. Yet despite this increased association of 
PTOA, acute injuries might not be treated appropriately with PTOA in mind,4 putting 
many adults at risk for developing PTOA. It is estimated that 5.6 million Americans 
are affected by PTOA, with 12% of OA cases being attributed to PTOA.10 The 
financial impact of PTOA is large, with an associated economic cost of almost $12 
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billion (US dollars).10 PTOA is a widespread problem that many adults will 
experience, although many patients and physicians may not appreciate the increased 
risk. 
PTOA can progress undiagnosed for years because subtle changes and 
degeneration in cartilage can occur while the joint remains grossly normal. After 
prolonged, long-distance running, changes in the orientation of the superficial zone 
collagen can be detected by polarized light microscopy of histological sections of 
cartilage. However, cartilage thickness, total collagen, and gross appearance do not 
change.11 This suggests that subtle structural changes might not be detected during 
typical evaluation of cartilage degeneration, particularly during visual (arthroscopic) 
examinations. Physical examination may also underdiagnose PTOA. In an 
experimental PTOA model in horses, initial lameness decreased after 1-2 months,12 
suggesting that in traumatic injuries, only a small period of time may exist to clinically 
detect pain during the initial inflammation stage. After the initial 1-2 month 
inflammatory stage, cartilage damage may no longer elicit enough clinical symptoms 
for the patient to seek healthcare. After this inflammatory period, diagnosis may 
become more difficult. Synovial fluid biomarkers may or may not be useful in the 
early stages of PTOA. Sulfated glycosaminoglycan (GAG) concentration is not 
significantly affected but cartilage oligomeric matrix protein levels are increased in 
metacarpophalangeal joint synovial fluid within eight months of mechanical trauma to 
cartilage.12 
Detecting cartilage injury is challenging. It may not be possible to detect 
cartilage damage radiographically within the first year of injury onset without 
comparing radiographs from post-injury to pre-injury.12 However, normal baseline 
radiographs may not pre-exist for an injured joint. While significant changes in 
radiographic evidence can be found when comparing the same pre- and post-impact 
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site, there is no significant radiographic difference between control and injured limbs 8 
months after trauma.12 Consequently, it may take several years for PTOA to develop 
after sustaining an injury. In a 36 year follow-up study, adults who had reported 
experiencing a knee injury prior to study enrollment were found to experience clinical 
symptoms of OA within 22 years (standard deviation=13 years) of enrollment.4 If 
cartilage damage is initiated at the time of joint injury, it may be difficult to diagnose 
in the early stages, which results in an increased risk of PTOA. 
 
Detecting cartilage damage 
There are currently no treatments that can return degraded cartilage to its 
normal, native state. Therefore, cartilage damage must be treated early to delay the 
progression to OA. In order to treat or modify the progression of early OA, 
degeneration or damage must be identified early. Cartilage is routinely evaluated 
during surgical procedures using an arthroscopic camera that provides optical 
magnification. Arthroscopic cameras provide greater details to a surgeon than the 
unaided eye. However, during arthroscopy, identifying early disease and determining 
the severity of disease is a qualitative process, and only the surface of the cartilage can 
be evaluated. Of over 31,000 arthroscopies performed in 1991-1995, chondral lesions 
were identified in 63% of the procedures, with almost 10% of the identified lesions 
being described as low grade—or, having softening of the cartilage.13 Low grade 
lesions can be challenging to diagnose with an arthroscopic camera, particularly in 
defining the border or depth of degradation. Of 105 experienced arthroscopists, most 
(61%) surgeons felt that differentiating normal and low-grade cartilage disease during 
arthroscopies was simple, 12% reported that differentiating normal and low grade was 
poor, and 22% reported that there is a need for improved differentiation.14 Not being 
able to clearly identify or define the extent of damage with small lesions may result in 
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inadequate treatment.  
Physicians would be able to more readily provide effective treatments to 
patients by having the ability to objectively evaluate cartilage integrity. There is a 
need for advanced technology to accomplish this objective. An overwhelming 
majority (75%) of surgeons reported that being able to use an objective measurement 
during surgery would be very or somewhat useful.14 If such an instrument were 
available, 88% of surveyed surgeons would use it: 16% reported that they would use it 
every time, and 72% would use it in questionable cases.14 In addition, an objective 
measurement during arthroscopic examination could be utilized when the primary 
pathology is not a cartilage lesion. Almost 40% of primarily pathologies found during 
knee arthroscopies in young adults between the ages of 20 and 30 were ACL 
injuries.13 In such cases where cartilage damage may not be the primary injury, a 
highly resolved, objective instrument may help to identify secondary cartilage injury. 
An objective, quantifiable measurement could help to determine the boundary of a 
non-distinct lesion, the integrity of cartilage bordering a distinct lesion, and the 
presence of secondary cartilage damage that may have occurred during a different 
primary injury, such as a ligament tear. 
Recent and developing improvements in cartilage imaging can make detailed 
evaluation of cartilage possible by providing quantifiable measurements. The three 
non-invasive clinical modalities most often used to diagnose cartilage disease are: 
radiography, magnetic resonance imaging (MRI), and computed tomography (CT). 
Radiographs are most often used first as a screening method. However, radiographs 
cannot be used to characterize changes with cartilage and instead are commonly used 
to identify osteophytes associated with late-stage OA. MRI and CT can be used to 
diagnose changes within the cartilage. However, they are currently limited in their 
resolution, failing to identify small regions of damage that could be the most useful in 
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early stage diagnosis. MRI and CT are more likely to underdiagnose than 
overdiagnose cartilage defects.5,6 Future advancements will improve MRI and CT 
capabilities in detecting early damage, such as with improved contrast agents and 
instrumentation. In vivo or arthroscopic imaging that is also being developed has 
higher resolution capabilities than MRI and CT and can provide additional, unique 
biological information. These in vivo techniques include optical coherence 
tomography (OCT), ultrasound imaging, bioelectricity including both streaming 
potential measurement and non-invasive electroarthrography (EAG), and multiphoton 
microscopy (MPM). These techniques all provide high detailed information about 
cartilage structure, which can sustain subtle changes that are not grossly apparent.11 
 
Magnetic Resonance Imaging 
MRI is a widely accepted, ex vivo imaging technique that can be used to quantify 
cartilage extracellular matrix and identify changes in the matrix associated with early 
OA. Traditionally, radiographic measurement of joint space width (JSW) has been 
used for diagnosing cartilage degradation, with decreased JSW presumably correlating 
with thinning cartilage. By using similar correlative measures, MRI can detect 
increased hydration that occurs during cartilage degeneration. While both methods 
indirectly diagnose cartilage degeneration, MRI quantification of cartilage thickness is 
more sensitive in identifying changes within the knee than radiograph quantification of 
JSW.15 MRI can detect cartilage degeneration early: using T2* values, degenerative 
cartilage has been identified at 4 weeks after anterior cruciate ligament transection in 
rats with 4.7T MRI.16 
MRI works by exciting and then detecting the relaxation time of proton spin, 
from excited state back to steady state. The location of the protons being detected is 
typically in unbound, water in cartilage. Proton MRI sequences in cartilage include T2 
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(spin-spin) weighted relaxation for indirectly measuring collagen quantity17 and 
orientation,18 T2* (spin-spin in inhomogeneous magnetic field19) to evaluate 
collagen,20 T1ρ (spin-lock) weighted relaxation for indirectly measuring proteoglycan 
quantity,17,21,22 contrast enhanced detection with gadolinium to measure GAG 
quantity,23 and magnetization transfer. Sodium can also be utilized for MRI to directly 
quantify proteoglycan concentration.24,25 
3T MRI has become standard for diagnosing cartilage injury. When 
comprehensive knee MRI scans are used and followed by arthroscopic procedure, both 
3T and 1.5T MRI can resolve cartilage lesions. However, 3T has an advantage over 
the weaker-field 1.5T MRI, with increased agreement between independent readers, 
less false-negatives for detecting lesions in 3T (9%) than 1.5T (12%), and higher 
sensitivity for detecting lesions in 3T (69%) than 1.5T of (60%) with multiplanar turbo 
spin-echo sequence.26 Sensitivity of 3T MRI in detecting lesions can be further 
increased by 14% with the addition of T2 mapping sequence.27 MRI signal is 
correlated with cartilage degeneration identified by biochemical, histological, and 
arthroscopic methods. T2 and T1ρ weighted-sequence measurements acquired with 3T 
are present in the same regions of cartilage with increased matrix metalloproteinase 
activity and decreased cellularity.22 This suggests that MRI may identify regions with 
altered biological activity.  
MRI can also help detect the progression of cartilage degeneration over time. 
When lesions are monitored longitudinally for 3 years, T2 and T1ρ signals increase over 
time, presumably as the lesions worsen.28 The use of contrast agents also increases the 
capabilities of 3T MRI to resolve cartilage degeneration. With the use of the 
negatively charged contrast agent gadolinium diethylenetriaminepentacetate (Gd-
DTPA; gadopentetate), 3D delayed gadolinium enhanced MRI of cartilage 
(dGEMRIC) provides an inverse relationship of GAG concentration23 that is highly 
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reproducible (intraclass correlation 0.87-0.95) when reimaging the same early OA 
knee.29 Overall, 3T MRI still fails to identify small or early lesions. MRI images read 
by trained radiologists as normal that were later identified as false-negative were most 
commonly classified as Noyes grade 1 during arthroscopy.5 This suggests that early 
OA can be missed with 3T scanning and that higher resolution scanning is necessary 
for these early stage cases. 
MRI at 7T has improved spatial resolution and shorter scan duration over 3T 
scanning due to the signal-to-noise (SNR) ratio of 7T being, in theory, 2.3 times 
higher than at 3T.30 Spatial resolution of 7T in human knee and hip has been 
demonstrated at ~200 µm x 200 µm x 1 mm to identify early cartilage changes.31,32 
This high voxel resolution can be particularly important to yield high details in other 
joints with thinner cartilage, such as the ankle. T1-weighted gradient echo sequences 
can be collected in one-third of the scan time with 7T than with 3T,30 which is 
beneficial in minimizing artifacts resulting from patient movement. In practice, the 
SNR improvement in 7T over 3T is dependent on the unique scan sequence, with an 
improvement of 86.7% in 2D PD-weighted fat-saturated fast spin echo and 60% in 3D 
T1-weighted gradient echo found when scanning human ankles. However, decreased 
performance in SNR of 25% was found with 2D T1 weighted spin echo, which may 
have been due to T1-weighted optimization.33 These varying SNRs suggest that results 
are highly sensitive to coil and protocol parameters. Commercially available coils for 
7T MRI scanning are limited mostly to proton knee coils, with in-house coils used to 
successfully scan deep tissue such as the hip with high resolution.32 The future clinical 
application and development of 7T proton and 23Na MRI may ultimately be hindered 
by the commercial availability of scan coils and subsequently protocol development. 
These similar deterrents were also historically present for 3T MRI, which is now 
standard of care in many radiology departments. 
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Non-proton 23Na 7T MRI34,35 is also being used to detect early cartilage 
degradation by measuring the change in concentration of 23Na associated with GAG 
loss.24,25 23Na has a high correlation with GAG concentration; however, 23Na MRI 
acquisition times can be long (>15 minutes). Techniques including compressed 
sensing by under-sampling k-space have been investigated to shorten scan duration.35 
23Na MRI may be a tool for diagnosing early cartilage degeneration, but this MRI 
technique still needs further development to provide higher resolution and faster scan 
times before being feasible for routine clinical use. 
 MRI has limitations. In-plane resolution is limited, making the imaging of 
early changes difficult, particularly in thin cartilage. In a systematic review, MRI was 
found to be accurate in detecting patellar (84%) and trochlear (83%) defects, but most 
traditional MRI sequences tend to underdiagnose, rather than overdiagnose, defects.6 
In joints where cartilage is less than 500 µm in thickness, early OA may involve only 
a fraction of the tissue. Even with 7T MRI single plane resolution of 200 µm, sites of 
early OA may be a fraction of this spatial sampling site and be missed. An ultra-high 
field, full body 11.7T MRI scanner is being developed for high resolution brain 
imaging, with reported a single plane resolution of 100 µm.36,37 This scanning method 
could provide improved detection of cartilage damage. Safety concerns will need to be 
addressed at this high field strength, especially with reporting of altered cognitive 
function resulting from magnetic stray fields near 7T scanners.38 A second limitation 
is that MRI typically measures proton relaxation in unbound water. These 
measurements may be affected by both macromolecule concentration and alignment, 
leading to relaxation times that may be attributed to solely matrix concentration. T2 
mapping cannot be used alone without additional scan sequences due to the potential 
effect of collagen degradation on T2 mapping values.27 However, contrast enhanced 
MRI such as dGEMRIC, dual gadopentatate and Mineric (trace element replenisher) 
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T1 and T2 sequencing,39 non-proton 23Na MRI, and magnetization transfer sequences, 
which rely on both unbound and bound water, may help to improve this particular 
limitation. Cartilage thickness measurements in MRI can be affected by joint loading 
prior to scanning. T2 weighted values in defects are higher in unloaded cartilage than 
cartilage that has been loaded prior to scanning.40 Patient activity prior to MRI 
scanning can create a potential confounding factor on measured cartilage thickness 
emphasizing the need of a standardized protocol for physical activity prior to scanning 
to minimize this effect. Lastly, the commercial availability of coils and protocol 
sequences may slow the progression of high resolution MRI. This limitation occurs for 
any new technological advancement and can be said for any method discussed herein.  
 
Computed Tomography 
Cartilage can be visualized with non-invasive CT. Multiple image slices and three-
dimensional reconstructions are created by computer-processing of x-rays, which yield 
detailed information about deep tissue. Using soft tissue kernel-based CT with post-
processing, CT can be used to identify regions of different thickness of articular 
cartilage within the human shoulder, with results similar to those found with MRI or 
anatomical sections.41 However, fine details of cartilage needed to identify early OA 
are not easily visualized with standard soft tissue CT imaging. Contrast agents and 
acquisition methods have made it possible to achieve high details of cartilage that 
correlate with MRI. When a combination of ioxaglate and gadopentetate is used with 
CT and the same ioxaglate-gadopentetate combination or solely gadopentetate is used 
with MRI, CT and MRI findings of cartilage strongly correlate (R=0.65).42 This 
suggests that either imaging modality could be used to detect cartilage disease, which 
is beneficial to facilities that have limited equipment resources.  
Contrast agents are commonly used during CT imaging of cartilage. Clinical 
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contrast agents are typically anionic and either iodine (e.g., ioxaglate) or gadolinium 
(e.g., gadopentetate, also used in MRI) based. Iodine and gadolinium contrast agents 
can be readily visualized with CT. Contrast agents work by being excluded from or 
attracted to the cartilage matrix. GAGs are negatively charged and repel anionic dyes 
and attract cationic dyes. Imaging with anionic contrast dyes is achieved because 
anionic dyes are concentrated in regions with little GAG such as in the synovial fluid 
and lesions, or alternatively, by being excluded from regions that are dense with 
GAGs such as normal cartilage. Healthy cartilage will have less anionic dye present 
than diseased cartilage that is depleted of GAGs. CT scanning with anionic, iodine-
based contrast dyes has been reported to both highly correlate (anionic tri-iodinated 
dye, R2=0.8343) or poorly correlate (ioxaglate, R2=0.2,44 R=-0.6445) with biochemically 
measured GAG content by dimethylmethylene blue (DMMB) assay43,44 or safranin-O-
staining.45 Different types of anionic iodinated dyes, levels of degradation, and lengths 
of dye incubation can contribute to differing results of CT imaging. Optimizing the 
methods for in vivo dye incubation could help the dye and GAG correlation, and 
subsequently, clinical diagnosis. Ioxaglate can detect small cartilage injuries in as little 
as 3 hours after trauma;46 however, anionic dyes take over 29 hours for diffusion to 
reach near-equilibrium state.47 Cartilage injury can be detected in almost a tenth of the 
time needed for dye to reach the diffusion equilibrium within cartilage, but the 
accuracy of quantifying the severity of injury may be limited with a 3 hour incubation. 
In addition, ioxaglate does not cross the bone-cartilage interface,45 suggesting that 
intra-articular injection may be more effective than intravenous injection. 
The use of CT with cationic contrast dyes provides a solution to the limitations 
with anionic dye exlcusion. Cationic dyes have a direct correlation with negatively 
charged GAGs. Cationic dyes like CA4+ have a higher correlation with GAG 
(R2=0.83) than negatively charged dyes (ioxaglate R2=0.2; gadopentetate R2=0.22).44 
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Further development is necessary to help achieve detailed imaging of cartilage with 
anionic and cationic dyes that have high correlation to matrix biochemical properties.  
Cartilage can be imaged using CT without contrast agents with new acquisition 
methods. Normal and OA human patellar cartilage can be identified with phase 
contrast imaging (PCI) X-ray CT (PCI-CT). In PCI-CT, a highly collimated X-ray 
beam is delivered to the sample, and emerging, refracted, and scattered radiation is 
collected and converted to visible light. These data are analyzed to determine an 
apparent “pattern” or “texture” of the matrix and the distribution of chondrocytes. 
While this method is being tested with ex vivo samples, it may have a future role with 
adaptation for detecting small matrix defects, with its high resolution of 8 µm x 8 µm 
per pixel.48 Use of the highly collimated X-ray beam in a synchrotron facility will 
need to be adapted for clinical use and safety. 
 CT resolution has been further improved to micron resolution. µCT can 
provide higher resolution imaging for ex vivo samples or in vivo imaging of small 
specimens. µCT has a resolution of 25 – 85 µm3 voxels, with some µCT systems 
having the capability to go lower.44,49 These instruments often have a small bore for 
the sample, due to the set up of detectors. This limits µCT potential to use for smaller 
applications, such as the hand or ankle. Further clinical research would be needed to 
determine the safety of using µCT with patients, but equipment and acquisition 
techniques could reduce µCT radiation exposure to similar levels of current clinical 
CT.50 
 CT has similar potential and limitations as MRI. CT can detect early cartilage 
degeneration but is less able to identify small cartilage lesions. CT and MRI are more 
effective than radiographs and are useful instrumentation for initial diagnosis, prior to 
arthroscopic procedures. PCI-CT and µCT may both be able to provide great details 
about cartilage disease, but further development needs to be performed prior to clinical 
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application. If PCI-CT and higher resolution µCT can be combined with contrast 
agents for clinical use, this tool could be extremely functional for non-invasive 
cartilage evaluation. 
 
Optical coherence tomography 
 OCT provides, in general, a cross sectional view of cartilage from an 
arthroscopic or open-joint approach. This imaging technique is achieved by collecting 
the back-scattering of infrared light, which provides deep penetration of tissue to 
reveal subsurface defects.51 Using OCT, the integrity of the cartilage collagen matrix 
can be assessed, the thickness of cartilage can be measured, and the bone-cartilage 
interface can be evaluated. 
A hand-held OCT probe52 can be inserted arthroscopically, such as through a 
0.9 mm portal, or smaller for a less invasive, non-surgical technique.53 OCT has an in-
plane resolution of about 10 µm53,54 and depth penetration of up to about 1.5 mm55 to 
visualize thinning, fibrillation, and birefringence. Modified Mankin scoring of OCT 
optical sections and histological slide sections have a high agreement (κ=0.80),51 
suggesting that OCT can serve as an effective method to assess deeper tissue that 
cannot be seen with a standard arthroscopy lens. OCT signal intensity and edge 
variance correlates with 313 µm x 313 µm resolution, T2 mapping in MRI.55 
Using different evaluation methods, including ICRS lesion scoring 
parameters,53 OCT roughness index (ORI),56,57 optical surface reflection coefficient 
(ORC),56,57 variation of surface reflection (VSR),57 and optical backscattering 
(OBS),57 cartilage degradation can be quantified. ICRS scoring with OCT can provide 
an overall assessment of cartilage disease but has only moderate correlation with 
standard arthroscopy (R=0.503).53 ORI, ORC, VSR, and OBS can be used to detect 
cartilage injury caused by mechanical trauma.57 ORI and ORC decrease in bovine 
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cartilage treated with collagenase but not trypsin, suggesting OCT may be more 
sensitive to changes in collagen than GAG.56 This is not surprising because OCT relies 
on reflection, and collagen is reflective, unlike GAGs. 
OCT has the resolution to differentiate cartilage zones due to the different 
refractive indices (RI) among zones.58 However, different RIs have been reported 
between species in the literature,58,59 which can affect cartilage depth measurements. 
This suggests that optimization of imaging parameters may need to be outlined prior to 
evaluating the images of cartilage. Furthermore, when acquiring OCT images, if the 
probe is not perpendicular to the surface, ORI, ORC, VSR, and OBS can be affected.57 
OCT has an in-plane resolution of about 10 µm, which is about the size of one cell. 
However, OCT cannot discern cellular viability or morphology. The inability of OCT 
to provide biological details is a disadvantage shared with MRI and CT. No in vivo 
clinical imaging techniques can provide cellular level details, and much of the 
information concluded about the “health” of cartilage is based on matrix structural 
changes. 
 
Ultrasound 
 Ultrasound imaging of cartilage is acquired by collecting the echoes of pulsed, 
high frequency sound waves that are transmitted externally to the joint or 
arthroscopically to the cartilage. The transmitted and collected sound waves will be 
different from each other, after interacting with a surface or tissue. Sound waves can 
be attenuated (reduced amplitude and intensity) by reflection, scattering, and 
absorption; or refracted (altered direction and velocity). Interaction with different 
tissue—whether it is bone or cartilage, or healthy or diseased tissue—will cause 
different attenuation or refraction of sound waves, which can be used to characterize 
the properties of the tissue. In arthroscopic surgery, this information can provide 
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details about the integrity of cartilage matrix to a greater depth than can be visualized 
with an arthroscopic lens, allowing previously unidentified lesions to be diagnosed 
and treated. 
 Non-invasive ultrasound can be used to identify OA. The axial resolution of 
non-invasive ultrasound is <1.0 mm at 13 MHz,60 providing gross details of cartilage 
and bone. Non-invasive ultrasound is moderately correlated with both in vitro 
ultrasound and histological findings (Spearman ρ=0.41-44 and 0.39-0.44, 
respectively).61 In the knee, scoring cartilage degeneration by non-invasive ultrasound 
correlates with the same adapted Noyes’ scoring system performed with an 
arthroscopic camera. Correlation of ultrasound and arthroscopy is site dependent in the 
knee, with the femoral sulcus (R=0.593) and medial femoral condyle (R=0.465) being 
moderately correlated, but the lateral femoral condyle (R=0.262) having non-
significant correlation.60 
 Arthroscopic ultrasonographic imaging can provide greater details than 
external ultrasound and help visualize areas not possible with external ultrasound, 
such as under the patella in the knee. Several measurement parameters can be used for 
arthroscopic or in vitro ultrasonographic imaging. Ultrasonic reflection coefficient 
(R),62,63 integrated reflection coefficient (IRC),64 ultrasonic roughness index (URI),64 
apparent integrated backscattering coefficient (AIB),64 wave echo,65,66 and wave 
magnitude and velocity65,66 have all been reported in the evaluation of cartilage. R, 
IRC, and AIB show low coefficient of variation when imaging different cartilage sites, 
whereas URI is more variable.64 Wave echo duration and magnitude are similar among 
joints, such as knee and ankle, when evaluating healthy cartilage.66 
Arthroscopic and in vitro ultrasonography can be performed using low (~10 
MHz) or high (20-50 MHz) frequency wavelengths. Lower frequencies allow for 
deeper imaging than higher frequencies but have lower resolution images than higher 
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frequencies can provide. Low frequency ultrasonography can be used to visualize both 
cartilage and bone, whereas high frequency can provide greater details of the surface. 
Using low 9 MHz frequency that can penetrate to the subchondral bone, R, IRC, URI, 
and AIB can be used to discern the cartilage-bone interface, making the measurement 
of cartilage thickness possible.64 With 9 MHz frequency, reflection coefficients R and 
IRC can be used to identify natural cartilage disease, and these measurements correlate 
with histological Mankin scoring (R>0.56). Neither URI, with its high variability, nor 
AIB significantly correlates with histological evaluation,64 suggesting that R and IRC 
may be better parameters than URI or AIB for grading cartilage degeneration at low 
frequency. Wave echo duration and magnitude measurements can resolve cartilage 
lesions when using lower resolution 10 MHz frequency.66 
Higher frequency sound waves such as 20-50 MHz can help capture greater 
details of cartilage during arthroscopic or in vitro imaging but at the loss of imaging 
deep tissue. The axial resolution of 20 MHz ultrasound has been reported to be 60 
µm63 and 30 µm at 50 MHz.67 High frequency ultrasound of 40 MHz can still be used 
to visualize the cartilage-bone interface in sites of thinner cartilage, up to ~1.65 mm.68 
Surface roughness62,63,68 and degradation63,68,69 can be visualized at this resolution. 
Using in vitro 20 MHz ultrasound, reflection coefficients R and IRC decrease and URI 
increases after either mechanical surface abrasion63 or collagenase treatment,63,65 
suggesting that these measurements could identify cartilage matrix that has structural 
damage. In cartilage treated with chondroitinase, R, IRC, and URI are not significantly 
different,63 indicating that these measurements do not identify GAG loss. Instead, a 
new echo pattern or altered sound velocity can be used to resolve the edge of 
chondrointinase degradation and subsequent GAG loss.65 The depth of cartilage 
degeneration that results from trypsin degradation can be measured using 50 MHz 
ultrasound, which significantly correlates to histological measurements (R2≥0.63).69 
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The depth of degeneration quantified with ultrasonography, however, tended to be less 
than the depth that was quantified with histological sections,69 suggesting that 
ultrasonography may be generally limited in detecting GAG loss. 
Ultrasonographic imaging can be adapted for arthroscopic procedures using a 1 
mm diameter instrument. R, IRC, AIB have a high correlation with ICRS grading 
performed during arthroscopic examination (R=0.939), with differences being skewed 
toward more severe scoring by ultrasonography.68 This moderate difference is likely 
due to the ability of ultrasound to discern degradation below the surface. R and IRC 
are decreased and URI is increased in both mechanically damaged cartilage70 and 
naturally occurring fibrillated cartilage.68 
Ultrasonography has similar potential applications and limitations as OCT. 
Non-invasive ultrasonography may be a potential screening method to replace or 
compliment radiograph screening. Current investigations of the optimization of 
acquisition parameters for different diagnostic applications will help to improve 
ultrasonography use for cartilage evaluation in the clinic.  
 
Bioelectricity 
 Cartilage degeneration can be evaluated by capitalizing on its bioelectrical 
properties. Streaming potential due to positively-charged sodium ions and negatively-
charged GAGs71,72 or bulk electrical impedance due to water content73 can be used to 
assess the integrity of cartilage, which can be graded with both non-invasive, external 
methods and in vivo methods. 
 By loading and unloading the knee, fluid flow generates a flux of sodium ions 
that creates a streaming potential that can be measured both non-invasively and in 
vivo. Streaming potential can be detected with EAG, where electrodes are placed on 
the skin near the joint line.72 Significantly different streaming potentials can be 
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detected between normal and OA knees using EAG. However, repeatability of 
measurements within a normal knee is site dependent, with some sites closer to the 
joint line being more consistent than those farther from the joint line.72 Site 
dependency could affect results when evaluating a joint for disease, particularly if the 
test is performed by different clinicians. The potential diagnosis of OA using non-
invasive streaming potential by EAG is promising, particularly among other 
developing cartilage techniques that require invasive procedures. EAG may be 
effective for initial OA screening as a diagnostic tool that is directly reflective of 
cartilage degeneration, unlike radiographs. The relatively low resolution of EAG 
makes it inappropriate for fine-tuned diagnostics. Improved repeatability and 
adaptation for other joints need to be addressed prior to clinical application. 
 Electrical streaming potential can also be measured arthroscopically. 
Measurements of the electrical streaming potential in vitro and in vivo are sensitive 
and can detect changes in the matrix after enzymatic degradation, including by 
chondroitinase or trypsin,74 and mechanical injury.75 The streaming potential integral 
(SPI) can be measured by indenting the cartilage surface with an arthroscopically-
designed probe. SPI has been shown to correlate with ICRS and Mankin scores (R=-
0.749 and -0.409, respectively).76 SPI measurements are significantly different 
between normal cartilage and moderately to severely mechanically-injured cartilage 
resulting from 28-49 MPa loading.75 The logarithm of SPI also correlates with 
cartilage thickness (R=-0.496), suggesting that it may be applied clinically for 
determining the differences in site-to-site cartilage-bone interfaces.76 SPI has a high 
intraclass correlation between repeated measurements by different users 
(ICC=0.861).75 However, the sensitivity of SPI is limited and fails to detect a 
significant difference between normal cartilage and mild injuries created by 17 MPa 
loading.75 SPI may be able to compliment an arthroscopic examination by providing 
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details of deeper cartilage, but it might be limited in the additional information it can 
provide. By improving the sensitivity of in vivo SPI measurement, this high inter- and 
intra-user repeatable technique could be a promising tool to compliment current 
arthroscopic imaging. 
 The electrical impedance, a characteristic of the bulk electrical property of 
cartilage, can be measured ex vivo to detect degraded cartilage. Unlike streaming 
potential that is dependent on the local cartilage properties, electrical impedance is 
dependent on the bulk of the tissue. In an ex vivo setting, a cartilage explant is placed 
between two electrodes, and a voltage is applied to measure impedance. Impedance in 
cartilage is dependent on the permeability of cartilage to water, and this permeability 
changes when cartilage is degraded. The electrical resistivity significantly decreases 
after hyaluronidase or collagenase treatment, and the amplitude of change is 
dependent on the duration of treatment with enzymes.73 This concept has potential to 
be used in a clinical setting to diagnose altered matrix integrity. This method needs 
further development before it can be adapted to in vivo use.73 
  
Multiphoton microscopy 
Cartilage damage can be visualized at the cellular level using MPM.77,78 MPM is a 
microscopy technique that uses pulsed, infrared photons to acquire sub-micron79 
images of intact, live tissue to approximately two hundred microns in z-depth.80 MPM 
images are gathered by utilizing both the backscattering of excitation photons in the 
nonlinear optical process called second harmonic generation (SHG) and the two-
photon excitation of both autofluorescent molecules within unstained tissue and 
fluorescent dyes added to tissue. MPM images can be acquired from intact and 
unstained tissue, providing cellular resolution with great z-depth that is not available 
with other microscopic, in vivo, or non-invasive imaging techniques.   
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Cartilage extracellular matrix can be visualized using both SHG and 
autofluorescence. Collagen in cartilage matrix has a strong SHG emission,81 which can 
be used to identify and quantify cartilage damage. Quantification of SHG detects 
differences in collagen content between normal and repair cartilage and correlates with 
polarized light microscopy (R=-0.76).78 When cartilage is subjected to freezing to 
create structural changes in collagen, SHG intensities become diminished.82 However, 
unlike immuno-staining and polarized light microscopy techniques that require sample 
processing, SHG with MPM can be used to evaluate matrix collagen in live, intact 
cartilage samples. Cartilage matrix also contains molecules like elastin83 that 
autofluoresce to provide information about extracellular and pericellular matrix.79 
Individual elastin fibers, elastin fiber branching, and diffuse pericellular elastin  can be 
resolved with MPM.83 Disruption of the elastin fiber network could be used to identify 
regions of cartilage damage. Diminished pericellular elastin autofluorescence could be 
a potential tool to indicate compromised chondrocytes. Fine details of the cartilage 
matrix integrity can be evaluated when SHG and autofluorescence are combined, 
including cracks as small as 2 µm that result from mechanical trauma.77 This type of 
small structural damage that can be identified with MPM is undetectable with other in 
vivo imaging techniques. 
MPM can resolve damaged regions of cartilage through the use of dead cell 
stains77 and evaluation of matrix diffusivity.84 Individual cells can be identified to 
determine specific regions of increased cell death, such as near matrix cracks that are 
below the resolution of previously discussed imaging techniques.77 MPM can also be 
used to monitor cartilage matrix diffusivity, or the diffusion and flow of molecules in 
cartilage.84 This technique could identify regions of diseased cartilage, where diffusion 
may be altered from either changes in GAG concentration or structural loss of matrix 
integrity such as cracking. The ability to detect changes in cell viability and changes 
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within the cartilage matrix by cell diffusive properties would aide in the diagnosis of 
diseased cartilage. 
MPM has not been used clinically to evaluate cartilage, but recent work in 
other medical fields85-88 and in ex vivo studies82, 84 suggests that MPM has potential as 
a diagnostic tool. MPM imaging is being investigated in the oncology field because of 
its ability to resolve differences between normal and cancerous skin and lung 
tissue.85—88 The potential of MPM in the medical field is being realized because it can 
detect differences between normal and abnormal tissue, particularly in early stage 
disease before abnormalities are detectable with other imaging modalities. MPM can 
be used to identify small (<2 µm) regions of injury in cartilage in an ex vivo setting77 
but will require adaptation before it can be used clinically. With clinical adaptation, 
small cartilage damage can be detected to aide in early treatment and mitigation of 
PTOA progression. High resolution longitudinal studies that have not previously been 
possible could be performed with arthroscopic MPM to help determine the minimal 
threshold of damage that degenerates into PTOA and evaluate corresponding 
therapeutic targets. 
 
Conclusion and future directions 
Identifying and understanding changes in cartilage immediately after injury will 
benefit patients both directly in the clinic and indirectly through the advancement of 
PTOA treatments. Current clinical imaging modalities MRI and CT do not provide 
resolution that is high enough to identify small cartilage injuries. While OCT, 
ultrasound, and electric streaming potential provide increased resolution over MRI and 
CT, they do not have the submicron resolution or cellular detail that MPM provides.  
With clinical adaption, MPM could be used during arthroscopies to define the 
border of damaged and healthy tissue near a lesion, to provide cellular and structural 
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details of a low grade cartilage damage, and to evaluate regions of cartilage that may 
have received trauma during an injury such as an anterior cruciate ligament tear. 
While the application of MPM is broad, it would most likely be used during cases 
where an arthroscopy was recommended based on physical exam and MRI or CT 
imaging. It is unlikely that a patient would be referred for arthroscopic MPM simply 
because of traumatic injury, and instead MPM would be used to compliment the pre-
operative diagnosis and arthroscopic examination. The complimentary imaging can 
help detect small damage so that early treatment can be provided to mitigate further 
damage and development of PTOA. Use of MPM to identify optical biomarkers might 
lead to the discovery of PTOA chemical biomarkers that could be detected in blood or 
urine tests to monitor the presence or progression of PTOA and response to 
therapeutic intervention. 
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ABSTRACT 
Objective. Cartilage injury can lead to post-traumatic osteoarthritis (PTOA). 
Immediate post-trauma cellular and structural changes are not widely understood. 
Furthermore, current cellular-resolution cartilage imaging techniques require 
sectioning of cartilage and/or use of dyes not suitable for patient imaging.  In this 
study, we used multiphoton microscopy (MPM) data with FDA-approved sodium 
fluorescein to identify and evaluate the pattern of chondrocyte death after traumatic 
injury. 
Method. Mature equine distal metacarpal or metatarsal osteochondral blocks (OCBs) 
were injured by 30 MPa compressive loading delivered over 1 s. Injured and control 
sites were imaged unfixed and in situ 1 h post-injury with sodium fluorescein using 
rasterized z-scanning. MPM data was quantified in MATLAB, reconstructed in 3-D, 
and projected in 2-D to determine the damage pattern. 
Results. MPM images (600 per sample) were reconstructed and analyzed for cell 
death. The overall distribution of cell death appeared to cluster into circular (n=7) or 
elliptical (n=4) patterns (p=0.006). Dead cells were also prevalent near cracks in the 
matrix, with only 26.3% (SE=5.0%, p<0.0001) of chondrocytes near cracks being 
viable. 
Conclusion. This study demonstrates the first application of MPM for evaluating 
cellular-scale cartilage injury in situ in live tissue, with clinical potential for detecting 
early cartilage damage. With this technique, we were able to uniquely observe two 
death patterns resulting from the same compressive loading, which may be related to 
local variability in matrix structure. These results demonstrate proof-of-concept MPM 
diagnostic use in detecting subtle and early cartilage damage not detectable in any 
other way.  
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INTRODUCTION 
Osteoarthritis (OA) is a degenerative, multifactorial disease affecting the world 
population.1-3 Knowledge of severe cartilage damage has led to therapies targeting 
symptom management, but understanding the early events in OA can facilitate the 
development of effective modalities in disease intervention. However, limited high 
resolution imaging of cartilage damage in the clinical setting has hindered early 
disease identification. Current medical imaging modalities including magnetic 
resonance imaging (MRI) and computed tomography (CT) do not have the resolution 
necessary to detect small cartilage injuries that can occur after joint trauma which lead 
to post-traumatic osteoarthritis (PTOA). Without the ability to detect these micron-
sized structural or cellular changes, it is difficult to understand the progression of 
PTOA and facilitate its prevention. Developing methods for detecting early cartilage 
damage in vivo can expand the understanding of cartilage degeneration immediately 
after tissue damage.  
Multiphoton microscopy (MPM) is capable of imaging live biological samples, 
including cartilage at submicron resolution, yielding structural details at depths greater 
than possible with confocal microscopy.4 Importantly, MPM can be adapted for in vivo 
imaging with diagnostic application, including distinguishing normal vs abnormal or 
cancerous tissue,5-8 and it is being developed into a fast-scanning endoscope.9 
Diagnostic in vivo MPM can be adapted to cartilage because of the high collagen 
content of the cartilage extracellular matrix (ECM). Collagen emits second harmonic 
generation (SHG), making it readily detectable without staining.10 Collecting SHG 
signal allows the general collagen matrix of the cartilage to be easily observed. 
Additionally, many molecules autofluoresce with MPM,4 and additional dyes may be 
used to further characterize tissue. Although fluorescent techniques have greatly 
expanded our understanding of cell biology, fluorescent labeling typically uses dyes 
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that are unsuitable for clinical use. Sodium fluorescein is FDA-approved and is used 
ophthalmologically or intravenously to diagnose blood vessel disorders and corneal 
abrasions. Sodium fluorescein has been shown to stain cells11 by binding non-
specifically to proteins,12 making it an attractive method to label cells that have 
compromised membranes and may be dead. Imaging in a highly fluorescent solution 
like fluorescein can be difficult, but the optical capabilities of MPM make it possible. 
SHG and fluorescein can be used to collect high resolution information from live 
tissue to study the mechanisms involved in the progression of cartilage damage. 
The importance of understanding the early sequence of events between 
cartilage trauma and OA is at the forefront of arthritis research.2,13-15 Cell death has 
been shown to occur after traumatic injury,2,15 but the immediate effect of compressive 
trauma on chondrocyte viability15 and the resulting dispersion of cell death and matrix 
damage around the injury site have not been studied in detail. The spatial distribution 
of chondrocyte death may be influenced by many factors. The superficial zone has 
been shown to be more susceptible than deeper cartilage layers to compressive 
injury.16 This phenomenon may result from zonal ECM composition and collagen 
orientation, which distribute load when force is applied.17,18 Evaluating chondrocyte 
death distrubtion in the superficial zone with MPM can further elucidate these 
underlying structural factors. 
The goal of the current study was to use MPM to evaluate cellular damage 
after cartilage injury ex vivo in live tissue using an FDA-approved dye to detect 
chondrocyte death. Specifically, by using MPM with sodium fluorescein, we evaluated 
the pattern of chondrocyte death in the superficial zone immediately following 
traumatic injury like that which could contribute to the development of early PTOA. 
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METHODS 
Tissue collection and injury model 
The distal third metacarpus (n=3) or metatarsus (n=8) was harvested from the left 
(n=5) or right (n=6) limb of young adult horses (n=10, ages 4-6 years) immediately 
after being euthanized for reasons unrelated to this study under the guidelines and 
approval of the Institutional Animal Care and Use Committee. The limb was chosen at 
random. Cartilage was grossly evaluated and scored using the International Cartilage 
Repair Society (ICRS) Cartilage Injury Evaluation System (www.cartilage.org). Only 
healthy samples (i.e., those receiving scores of 0, 1a, or 1b) were used for the study. 
Osteochondral blocks (OCBs) were initially placed in HBSS with 100 IU/ml penicillin 
and 100 µg/ml streptomycin and then transferred to phenol red-free MEM containing 
25 mM Hepes, 100 I.U./ml penicillin, and 100 µg/ml streptomycin. Dye-free media 
was used to prevent staining prior to microscopic imaging. In order to model early 
cartilage injury, OCBs were then briefly removed from the media and mounted 
between a custom-designed specimen-chamber and a 2.25 mm-diameter indenter on 
an EnduraTEC ELF3200 mechanical test frame (EnduraTec, Minnetonka, MN). The 
articular surface of the medial condyle, medial to the sagittal ridge and anterior to the 
transverse ridge, was injured under load-control with a single compression of 30 
MPa19 within 1 s (Fig. 2.1) (mean peak stress rate 118.5 MPa s-1 [95% confidence 
interval (CI) 115.7-121.3]; mean strain 63% [95% CI 52-74]; mean peak strain rate 
587% s-1 [95% CI 310-864]). The lateral condyle functioned as the control. After 
injury, OCBs were placed back into the media and incubated for 1 h at 37°C in 5% 
CO2. 
 
MPM data acquisition and staining 
After incubation, OCBs were placed in 1 µM sodium fluorescein (AK-FLOUR 25%,  
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Figure 2.1. Schematic of methods. (a) An osteochondral block is injured with 
compressive loading. The injured site (b) and corresponding control site (c) are 
each scanned with multiphoton microscopy using a rasterized pattern, alternating 
scanned and non-scanned regions to encompass a 3.3 mm x 3.4 mm area. 
Individual 328 µm x 438 µm images that comprise the larger rasterized scanned 
area are shown in (d) and (e), with arrows denoting fluorescein-labeled dead cells. 
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Akorn, Inc., Lake Forest, IL) in PBS. Fluorescein was chosen for this study because it 
is FDA-approved and has been previously used for determining tissue viability in vivo 
in both animals and humans.20,21 The ability of fluorescein to detect cell death was 
initially validated by dual staining of cartilage with 1 µM ethidium homodimer-1 
(EthD-1, Invitrogen, Grand Island, NY) and fluorescein. Imaging was performed using 
a lab-built MPM instrument, in which an uncompensated beam from a modelocked 
Ti:sapphire laser (Tsunami pumped with a Millennia Xs; Newport, Irvine, CA) was 
passed through an Electro-Optic Modulator (350-80LA; Conoptics, Danbury, CT) 
with laboratory-built electronics for beam modulation and blanking during scan fly-
back. The beam was then directed into a modified BioRad scanner (MRC-600) 
interfaced with a modified Olympus AX-70 upright microscope (Center Valley, PA). 
An excitation wavelength of 780 nm was delivered through an Olympus XLUMPlanFl 
20X/0.95NA water immersion objective to obtain MPM images.22 The emission signal 
was separated from the excitation beam using a 670 nm long-pass dichroic. Samples 
were placed in fluorescein solution for 10-15 min and then imaged within the solution. 
Data was collected first with fluorescein excited at 780 nm and collected through a 
380-540 emission filter. EthD-1 was then added and allowed to incubate for 30 min, 
after which the imaging was repeated with the added EthD-1 signal collected through 
a 560-650 nm emission filter in a second detection channel. Using this approach 
fluorescein was validated as an indicator of cell death, and dual staining with EthD-1 
was discontinued (n=9 sites, n=1 OCB). The remainder of the data was collected using 
only fluorescein. 
After injury, OCBs were positioned on the MPM stage, maintaining medial-
lateral orientation. The sample was imaged in the transverse plane with the same 
instrumentation as described above. Imaging was performed starting at the articular 
surface and penetrating 100 µm deep to encompass the superficial zone.23 Cartilage 
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SHG and autofluorescence, and fluorescein fluorescence were collected by 
photomultiplier tubes using a 360-490 nm filter for autofluorescence and SHG from 
the cartilage matrix, and a 510-650 nm filter for fluorescein emission. Each z-stack 
acquired emission from 328 x 438 µm section, with ten 10 µm z-steps. A rasterized 
tile scan with x=272 µm and y=312 µm sized steps acquired data from a large field 
4.528 x 4.938 mm area or small field 3.328 x 3.438 mm area of the injured region and 
surrounding tissue, and a respective scan of the control lateral condyle (Fig. 2.1, n=11 
OCBs). Z-stacks were collected starting at the cartilage articular surface. The tiling 
algorithm detected the articular surface based on the emission signal intensity. The z-
depth of the surface was recorded for subsequent 3D reconstruction. To minimize 
potential variation between samples resulting from the length of a high resolution tile 
scan, tiled images were collected in a grid with a reduced fill factor, resulting in 37% 
of the tissue being scanned. This fill factor was chosen in order to complete the small 
field scan within an hour. The small field scan was more readily utilized due to its 
shorter scan time. The large field was used on limited samples in order to confirm that 
the small field scan encompassed all dead chondrocytes. 
After the rasterized tile scan was completed, along with additional samples, 
cartilage was removed from the bone to image in the sagittal plane (control n=13 
OCBs from n=6 horses; injured n=10 OCBs from n=6 horses). This was performed to 
evaluate chondrocyte death at a depth greater than could be obtained by MPM imaging 
from the articular surface. Images were collected from a single z-depth penetration 
into the cross-section. 
 
Chondrocyte death identification with MPM data analysis 
Two-filter channel emission resulting from the transversely oriented, rasterized tile 
scan was processed in custom code created in MATLAB (MathWorks, Natick, MA). 
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All chondrocytes were identified in the 380-490 nm channel emission data using code 
similar to public MATLAB-published “Identifying Round Objects.” The MPM 
emission grayscale image was first thresholded to a binary black and white image 
(graythresh, im2bw). Objects in the binary image were smoothed (bwareaopen), and 
any holes were filled (imfill) to create solid objects. The boundaries of these solid 
objects were identified (bwboundaries). The properties for each object including 
boundary coordinates, centroid coordinates, area, and perimeter were recorded 
(regionprops). If the area and perimeter were each above given threshold values, both 
of which were optimized for each horse, the object and its centroid were recorded as a 
chondrocyte. To accommodate for clonal cells, which were difficult for the image 
analysis program to separate, threshold parameters were optimized for single, double, 
and triple clustered cells by allowing small, medium, and large sized objects that were 
then counted as one, two, or three cells, respectively. Threshold parameters were 
adjusted for each animal set due to the variation in image intensity, cell size, and cell 
clustering between animals. Injured and control images within one animal were 
analyzed using the same parameters. 
Dead chondrocytes were identified in the 510-650 nm channel. All object 
boundaries recorded from the code described above were evaluated in this channel. 
Each boundary was defined as the region-of-interest (roipoly), so that the presence or 
absence of fluorescein at this site could be determined. The mean intensity of the 
fluorescein image was first calculated; fluorescein-cells had an intensity above this 
mean, and an intensity threshold was optimized for each horse. If the bounded region 
was above this threshold, the cell(s) were recorded as dead. 
 
Death pattern processing 
The degree of circularity or ellipticity of the cell death pattern was determined for 
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each horse using MATLAB custom code that calculated eigenvectors and eigenvalues 
of two-dimensional projections of dead cell distributions obtained from tile scans. The 
covariance (cov) and central point (mean) of all dead cell centroid coordinates were 
calculated. The eigenvector and eigenvalues (eig) were calculated for the resulting 
covariance. The percent-difference between eigenvalues, or more simply the long- and 
short-axes, was then used to determine if the pattern of cell death was circular or 
elliptical, using a threshold of less than or greater than 30% percent-difference, 
respectively, between the long and short axes. 
 
Cell death near cracks and as a function of depth 
Z-stack images of the injured sites were examined to identify those that contained 
cracks within the ECM, which were similar to but not including the image shown in 
Fig. 2.2. Within these identified images, the z-stack image corresponding to 10 µm in 
depth from the surface was used for analysis, due to the clarity of the matrix. Within 
these images, each of the first three cells occurring within 100 µm distance from each 
crack was counted around the entire crack perimeter to determine cell death. Cracks 
were not observed in control samples. 
Images from two-filter channel emission data from sagittal plane scans of full-
thickness cartilage explants were manually stitched together. Then, all cells were 
manually counted at 50 µm steps, with fluorescein stained (dead) cells being recorded 
to calculate death as a function of depth. 
 
Statistical analysis 
The calculated percent difference between the eigenvectors of the circular and 
elliptical death patterns were clustered into their respective groupings and compared 
using a Wilcoxon rank sum test. A non-parametric test was used because the  
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Figure 2.2. Multiphoton microscopy images from a single-image plane within a z-
stack, from both control and injured samples. Signal from the 380-490 nm channel 
(blue) and 510-650 nm channel (green) have been merged for clarity, resulting in 
collagen SHG and ECM autofluorescence appearing blue-green and fluorescein-
stained cells appearing green. Control samples typically contained few fluorescein-
stained cells and had regular SHG signal within the ECM. Injured samples 
typically contained more fluorescein-stained cells and irregular SHG signal, 
resulting from damaged matrix, such as cracks. 
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difference was not normally distributed. Medians with ranges are reported. The 
percentage of chondrocyte death in the sagittal plane was evaluated at each 50 µm 
region using a two sample t-test, comparing control and injured samples. The same 
test was performed to compare chondrocyte death near cracks to controls. Statistical 
analyses were computed using Statistix 10.0 (Analytical Software, Tallahassee, FL) 
with p<0.05 considered significant. 
 
RESULTS 
Chondrocyte death identification from MPM data acquisition 
 MPM images provided high resolution detail of chondrocytes and the surrounding 
ECM. Each image collected was 328.7 x 438.3 µm in size. In separate studies, 
fluorescein was used with EthD-1 to verify that fluorescein can be used as an indicator 
of cell death. Cells were manually counted (n=9 sites, n=1 OCB), and fluorescein-
staining correlated to EthD-1-staining with a linear relationship of slope 1.049 and 
squared correlation coefficient r2=0.929 (Fig. 2.3). 
 Matrix-associated SHG signal allows for identification of chondrocyte lacunae 
as holes in the matrix. Control cartilage contained few chondrocytes with fluorescein 
staining. Images from the damaged regions contained more fluorescein-stained 
chondrocytes, autofluorescence, and irregular SHG signal, particularly near cracks 
(Figure 2). After injury, chondrocyte death was found to be significantly increased in 
the superficial 100 µm (Fig. 2.4, p<0.05). 
 
Chondrocyte death spatial dispersion 
The superficial 100 µm was evaluated in a medial-lateral (“x”) and anterior-posterior 
axis (“y”) coordinate system to understand the dispersion of cartilage death after 
traumatic injury in intact samples. A total of 420 control and 420 injured images for  
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Figure 2.3. Sodium fluorescein and ethidium homodimer-1 validation. Cartilage was 
stained with both sodium fluorescein and ethidium homodimer-1 to determine the 
linear relationship between dyes to validate sodium fluorescein as a dead cell 
indicator. The linear relationship with a slope 1.049 and squared correlation 
coefficient r2=0.929 was determined. 
 43 
 
Figure 2.4. Percentage of dead chondrocytes after injury, as a function of depth in 50 
µm steps, as measured in the sagittal plane. The box represents the depth to which 
transverse MPM images were acquired for rasterized tile scanning, as described in 
the methods. The line demonstrates the mean depth to which samples were 
compressed. A total of n=13 OCBs from n=6 horses were analyzed for controls; a 
total of n=10 OCBs from n=6 horses were injured. Data is represented as the mean 
± 95% confidence intervals. * represents a significant difference between control 
and injured (p<0.05) using a two-sample t-test. 
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each sample were collected in the large field, and 300 control and 300 injured images 
for each sample in the small field. Centroids of dead cells were plotted in 3-D (Fig. 
2.5) and projected into 2-D (Fig. 2.6) to determine the spatial pattern of damage. Dead 
cells were more numerous at the periphery of injury. The injury pattern was circular in 
some samples (n=7) and more elliptical (n=4) in others. Samples in which the percent-
difference between the two eigenvalues was less than 30% of the minor eigenvalue 
were considered to have a circular damage pattern (17.7%, range 5.6-23.8%), while 
those in which this percent-difference was greater than 30% were considered to have 
an elliptical damage pattern (59.6%, range 39.0-162.9%). These values were 
statistically different from each other (p=0.006). The median peak load and peak 
displacement did not vary between groups with circular and elliptical damage patterns 
(Table 2.1). 
 Images were selected to evaluate local chondrocyte death within 100 µm of 
cracks, as identified by the absence of SHG signal (Figure 2). Cell death within 100 
µm of cracks was significantly increased, with 73.7% (95% CI 64.0-83.4%, n=13 
images from n=5 OCBs, p<0.0001) of cells being dead, compared to the 
corresponding control site images with cell death of 1.0% (95% CI 0-2.2%, n=13 
images from n=5 OCBs). 
 
DISCUSSION 
This study used high resolution MPM imaging to determine the spatial distribution of 
chondrocyte death using a cartilage injury model. We demonstrated the feasibility of 
using MPM in live tissue, including collecting SHG signal and fluorescein emission, 
to detect subtle structural and cellular damage below the resolution of current clinical 
imaging techniques. With this technique, we were also able to identify two 
distributions of cell death that resulted from the same applied stress. 
 45 
 
Figure 2.5. 3-D reconstructions of control and injured cartilage. Each blue point 
represents a single dead chondrocyte in the control scanned site; each red point 
represents a single dead chondrocyte in the injured scanned site. 
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Figure 2.6. 2-D projections of control and injured cartilage. (a) A representative 
circular injury; (b) a representative elliptical injury. Each blue point represents a 
single dead chondrocyte in the control scanned site; each red point represents a 
single dead chondrocyte in the injured scanned site; the red lines represent the 
eigenvalues and eigenvectors; the transparent red shaded area denotes the area 
which corresponds with the eigenvectors.  
 47 
 
 Load (N) Displacement (µm) Axes Difference (%) 
    
Circular 117.74 (117.60-117.75) 319 (226-605) 17.7 (5.6-23.8) 
Elliptical 117.69 (117.67-117.74) 373 (319-425) 59.6 (39.0-162.9) 
    
 
Table 2.1. Median peak load (with range), median peak displacement (with range), and 
median percent-difference between the long- and short-axis (with range). The 
difference of 30% was used to classify groups into “circular” (n=7) and “elliptical” 
(n=4) damage patterns. 
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 SHG and fluorescein were used to detect structural damage and cell death as 
shown in Figure 2. Chondrocyte lacunae can be easily identified, even in non-stained 
cartilage tissue, due to the absence of SHG signal within the lacunae. In other imaging 
techniques where the ECM is not easily identified, multiple dyes must be added to 
identify the matrix and live or dead cells, but these dyes cannot be used clinically. In 
this study, fluorescein was shown to strongly correlate with EthD-1. Because sodium 
fluorescein is FDA-approved and can detect damaged cells, it shows promise as a 
diagnostic method for in vivo microscopic imaging of damaged cartilage. Overall, we 
were able to use one dye with MPM imaging to quantify early damage following 
cartilage injury in live cartilage.  
 Matrix damage was also identified using MPM due to the irregularities in 
SHG. Using SHG, cracks as narrow as 2 µm were identified and associated with 
significant increase in chondrocyte death. This finding is similar to previous work 
examining chondrocyte death near large cracks and fissures 18 h after injury.24 
Although we did not quantify SHG emission, work by Brockbank et al showed that 
thermally-damaged cartilage has decreased SHG,25 suggesting that SHG may be an 
additional measurement for damaged matrix, likely due to decreased collagen 
organization. Collagen organization was not determined because type II fibrils are 
generally sub-resolution in all types of optical microscopy. Overall, we were able to 
observe maximal information about the cellular and structural qualities of cartilage, 
while using a minimally invasive technique and labeling strategy. 
 MPM has been used as a diagnostic tool in other fields,5,8,9 and this study 
demonstrated the feasibility of applying MPM and fluorescein to arthroscopic 
evaluation of cartilage in vivo. Endoscopic MPM has been demonstrated,9 providing 
feasibility for MPM as an arthroscopic tool. Fluorescein could be readily added to 
fluids used routinely during arthroscopy. Other techniques for detecting cartilage 
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injury in live tissue, such as the work by Changoor et al. in examining 
electromechanical properties, are valuable but do not measure biological or cellular 
changes.26 Optical coherence tomography (OCT) and ultrasound imaging (UI) have 
also been used for high resolution evaluation of live cartilage. OCT resolution is 
approximately 10-30 µm,27-29 and UI is about 30-65 µm.30 While their x-y-resolution 
is not as high as MPM, OCT and UI have z-depth capabilities of 1.10 mm31 and 1.65 
mm,32 respectively. These techniques, however, only offer structural information. If 
UI is hybridized with fluorescence decay spectroscopy, biochemical information can 
also be ascertained,30 albeit without the imaging resolution of MPM. Overall, the 
present study demonstrated the unique high resolution capabilities of MPM to detect 
cartilage damage in intact, live samples with the expectation of adaptation for in vivo 
arthroscopy.  
 Using MPM, we were able to identify the distribution of chondrocyte death 
after injury. We utilized 30 MPa which, based on previous ground force reaction 
studies in the equine forelimb, is about two- to three-fold physiologic loading.33 These 
higher stresses have been shown to cause increased cell death19 and was similarly 
found to cause an increase in cell death in this study. Many biochemical and 
biomechanical changes occur following traumatic injuries,2,34 including decreased 
chondrocyte viability and increased catabolic gene expression.14-16,35 While these 
studies suggest that key changes such as gene expression occur immediately after 
injury, the immediate consequences of a single traumatic load on cell death 
distribution are not known and were therefore examined in the present study. OCBs 
were injured to evaluate death distribution as a model of rapid change after cartilage 
injury. Samples were compressed, based on previous work,19 with a loading rate 
similar to that which has been shown to result in surface fissures and large distribution 
of cell death in bovine metcarpal cartilage, 4 days after injury.35 In this latter study, 
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Ewers et al stated that their unpublished preliminary data suggested that the majority 
of cell death occurred within 3 h following injury.35 We specifically focused on cell 
death within this first hour to evaluate the immediate effects of mechanical injury and 
not of later apoptosis. MPM images of the most superficial 100 µm were collected. 
While other studies have removed the superficial layer prior to compression,36 Chen et 
al found that bovine cartilage subjected to sustained continuous or cyclical loading up 
to 5 MPa primarily has decreased viability in the most superficial 70 µm.16 After 
MPM acquisition, all lacunae were identified within the images, with the location of 
each dead chondrocyte being reconstructed and mapped. Overall, we found numerous 
dead chondrocytes at the periphery of the injured site, with fewer dead cells at the 
center of the injured site. This was not surprising because tissue under the center of the 
flat-ended indenter experiences high compressive strain and hydrostatic pressure, 
while the tissue at the edges of the indenter experiences high shear strains. Based on 
previous studies estimating shear stresses that produce cracks in cartilage in impact 
loading and finite element studies of local shear stresses during indentation, local 
shear stresses at the indenter edge were estimated to be 3.3-5.4 MPa.27,37,38 As in 
previous studies,39,40 cell death appears to be more prevalent in regions of tissue that 
experience high shear strain. Both with respect to x-y location, where cell death 
occurred preferentially near the edge of the indenter, and with respect to z-depth, 
where cell death occurred in regions within 200-400 µm from the surface, is the region 
known to experience highest shear strains. The dead-chondrocyte maps in the x-y 
plane were then analyzed using eigenvector analysis, and subsequently the axes of the 
spatial pattern to be calculated. This method was effective at revealing the patterns of 
cell death. 
 The observed injured samples were grouped into either circular (n=7) or 
elliptical (n=4) distribution patterns of chondrocyte death. All elliptical patterns were 
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found in metatarsus samples; however, due to the small metacarpus sample size, 
statistical analysis between the hind and forelimbs was not performed. These different 
precipitating patterns of cell death have not been previously described. Although care 
was taken to injure the same location in each specimen, there could have been slight 
variability in injury location due to the necessity of applying the load to the sample 
surface perpendicularly, and, therefore, also variability in cartilage matrix organization 
including orientation of collagen. Ugryumova et al has shown that the transverse 
orientation of collage in the superficial zone has a distinct pattern but varies highly by 
location.18 This suggests that in the present study, differences in collagen orientation 
between injured sites within a sample may have occurred even if the injury sites were 
within millimeters of each other. To minimize this variation in collagen orientation, 
the medial condyle was consistently used as the injury site.  While samples were not 
imaged prior to injury, the immediate surrounding regions near the injury site had a 
similar death staining pattern as the controls. Although only samples with an ICRS 
gross score of 0 or 1 were used, the background of the horses was unknown, which 
may introduce inter-animal variability. Collectively, these results suggest that the 
physiological consequences of trauma to the articular surface are site-dependent, 
which is important for understanding progression of PTOA between anatomic sites in 
patients.14,15 
 In summary, this study demonstrates the successful use of MPM imaging to 
detect cartilage damage in live tissue just one hour after injury. Cellular and structural 
changes that are below the resolution of other imaging techniques were readily 
identified with the fluorescein and MPM. Two unique injury patterns were observed 
suggesting that the cellular and structural consequences of injury are site-dependent or 
biologically variable. These findings may be significant for understanding, diagnosing 
and preventing PTOA development after injury. This study demonstrated the 
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feasibility of high resolution  MPM imaging of live, intact cartilage for application in 
vivo to further the understanding about the early pathogenesis of cartilage injury that 
may lead to PTOA. 
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ABSTRACT 
Osteoarthritis (OA) affects multiple joints. Studies typically evaluate a single joint or 
subset of joints, and the results are extrapolated to other, unrelated joints. In the 
present study, adult equine cartilage explants were harvested from eight major joints 
including the shoulder (SH), elbow (EL), carpal (CA), metacarpophalangeal (MC), 
patellofemoral (FP), tarsal (TA), metatarsophalangeal (MT), and proximal 
interphalangeal (PP) joints, and were injured by compressing with 30 MPa within 1 
second. Cell density, cell death, and gene expression were quantified. There were no 
statistical differences in cell density as a function of depth between joints. Overall 
injured samples had significantly higher cell death (17.55%, SE=0.01) than non-
injured samples (4.62%, SE=0.01, p<0.0001). Injury and joint had significant effects 
on cell death (p<0.0001). Expression of COL2A1 in controls was 13.9x lower in FP 
(p=0.0114) and 9.6x lower in SH (p=0.0460) than PP. Expression of CD-RAP in 
controls was 16.3x higher in PP (p=0.0098) and 14.6x higher in TA (p=0.0202) than 
FP. After injury, the change in CD-RAP expression increased 204% in FP over MC 
(p=0.0460). These results suggest that different joints have varying baseline 
characteristics and response to injury and may have different susceptibility to 
developing post-traumatic OA. 
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INTRODUCTION 
Osteoarthritis (OA) is a disease that affects the worldwide population.1 OA research is 
most often focused on a single joint, and these findings are then expanded to other 
unrelated joints. Presently, OA treatments and procedures are based on the concept 
that articular cartilage throughout the body is similar and that same treatment should 
be effective for all joints. With this inference, there is an assumption that joints are 
similarly susceptible to OA. Yet, the incidence of OA is not the same between 
different joints. In 500 patients with OA, the distribution of 847 affected joints was 
41.2% in knees, 30.0% in hands, 19.0% in hips, 4.4% in the tarsus, 3.2% in shoulders, 
1.6% in elbows, and 0.6% in the carpus.2 The hand can be subcategorized to further 
demonstrate this variability, where the prevalence of OA in the proximal 
interphalangeal and metacarpophalangeal joints in 1300 women was 16.5% and 6.8%, 
respectively.3 Within a single joint with compartmentalized articulating surfaces, such 
as the knee, there is varying incidence of OA. In a three year study, 24% of patients 
had radiographic signs of OA in the patellofemoral joint alone, 4% in the tibiofemoral 
joint, and 41% in both regions of the knee.4 Despite these differences in incidence of 
OA, the characteristics of multiple, OA-susceptible joints have not been widely 
compared to each other. Understanding the differences of healthy cartilage and the 
resilience to injury between different joints can help facilitate the development of OA 
therapeutics. 
Susceptibility to OA may be due to differences in stimuli response or 
biochemical or biomechanical properties in cartilage between joints. These differences 
have been shown in a small subset of joints. Knee and ankle cartilage respond 
differently to stimuli. Cytokine stimulation with interleukin-1β decreases the synthesis 
of glycosaminoglycans (GAGs) in the knee more than in the ankle.5 Mechanical 
stimulation increases aggrecan expression in the knee but does not change aggrecan 
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expression in the ankle.6 Knee and ankle cartilages have different biochemical and 
mechanical properties. GAG content and dynamic stiffness are higher in the talocrural 
joint than tibiofemoral or patellofemoral joints.7 If differences exist in this small 
subset of joints, differences might occur more widely among joints than previously 
thought. 
Cartilage properties are also highly variable within a single joint. The mean 
and maximal cartilage thickness of the same site within a single joint cavity varies 
between patients.8 In the knees of 27 patients, the thickest cartilage was determined to 
be on the patella in 22 patients, lateral tibia in three patients, and femoral trochlea in 
two patients.9 In the patella, maximal thickness from six normal cadaveric human 
knees varied 3.8-5.3 mm.10 In the tarsocrural joint, maximal thickness of the inferior 
tibial cartilage in 16 people varied 1.08-2.29 mm, as measured by MRI.11 If the same 
injurious load were applied to each of these individual cartilages, a different peak 
stress and strain would likely occur. Within the knee and ankle, mechanical properties 
of cartilage differ between regions of close proximity.12,13 The same traumatic stress 
would likely result in different damage depending on the specific site of injury.  
These biochemical and mechanical properties may result from differences in 
cell activity or density, or corresponding cartilage thickness. Chondrocyte density 
inversely correlates with the thickness of cartilage: thinner cartilage has a higher cell 
density (as many as 330,000 mm-3), while thicker cartilage has a lower cell density (up 
to 14,000 mm-3).14 In addition, the cell density in the superficial layer of thick cartilage 
has a lower cell density than thin cartilage.14 While the thickness of cartilage has been 
shown to be unrelated to the normal standing stress,15 lower weight-bearing regions 
have higher cell-to-matrix ratio than higher weight-bearing regions.16 The density of 
cells and how stress is distributed throughout the articulating surface may both be a 
factor in resiliency to cartilage damage and development of OA. 
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Current literature suggests that variability between major joints exists, both 
with respect to baseline cellular density, synthesis activities, and in response to injury. 
While injury has been well established to cause cell death in cartilage,17,18 difference 
between multiple joints in response to injury has not been studied. Understanding 
these differences will lead to be a better understanding of the unique progression of 
post-traumatic OA (PTOA) between joints and creation of more joint specific OA 
treatments. The goal of the present study was to evaluate cartilage in eight major 
joints, with the hypothesis being that cartilage in different joints would be inherently 
different, and joints with decreased in vitro cell death and increased post-injury 
anabolic gene expression would be the same joints that have a lower incidence of OA. 
 
METHODS 
Tissue collection and injury model 
Six millimeter diameter biopsy punches of full thickness cartilage were harvested 
aseptically from young adult horses (ages 2.5-4 years, n=4) immediately after 
euthanasia with approval from the Institutional Animal Care and Use Committee. 
Articular cartilage was harvested from the high impact region of caput humeri of the 
shoulder joint (SH), condylus lateralis radii of the elbow joint (EL), proximal surface 
of os carpale III of the carpal joint (CA),19 condylus lateralis metacarpi III of the 
metacarpophalangeal joint (MC),20,21 condylus lateralis phalanx proximalis III of the 
proximal interphalangeal joint (PP), condylus lateralis femoris/trochlea ossis femoris 
of the patellofemoral joint (FP),22 the distal surface of os tarsi centrale of the tarsal 
joint (TA),22 condylus lateralis metatarsi III of the metatarsophalangeal joint (MT).20-22 
Cartilage was grossly evaluated and scored using the International Cartilage Repair 
Society Clinical Cartilage Injury Evaluation System - 2000.23,24 Explants were equally 
divided into control and injury groups and then equally distributed for either imaging 
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or gene expression analysis (Fig. 3.1). Cartilage explants that were used for imaging 
were marked with standard permanent-marker ink at harvest to ensure that all images 
were acquired in the same anterior-posterior orientation. Explants were placed in 
phenol red-free MEM with 25 mM Hepes, 100 IU/ml penicillin, and 100 µg/ml 
streptomycin. 
Explants were briefly removed from media and placed in a custom-chamber 
containing the described media. The chamber was then placed under 2.25 mm-
diameter indenter on an EnduraTEC ELF3200 mechanical test frame (EnduraTec, 
Minnetonka, MN). The articular surface was injured with a single compression of 30 
MPa25 within 1 second. After injury, explants for imaging were immediately replaced 
into media and incubated for 60 minutes at 37°C at 5% CO2 to allow any immediate 
biological changes and cell death to occur. Gene expression explants were transferred 
to Ham’s F-12 medium, containing 25 mM Hepes, 2 mM L-glutamine, 50 µg/ml 
ascorbic acid, 30 µg/ml α-ketoglutaric acid, and 10% FBS and incubated for 48 hours 
at 37°C at 5% CO2 to capture changes in expression of a diverse profile of genes. 
 
Multiphoton data acquisition and analysis 
After the 60 minute incubation, explants were cut in cross-section and placed in 1 µM 
sodium fluorescein (AK-FLUOR 25%, Akorn, Inc., Lake Forest, IL) in PBS for 
multiphoton microscopy (MPM) imaging. Images were collected using a Tsunami 
titanium:sapphire laser (Newport Corp., Irvine, CA) with 780 nm wavelength at 100 fs 
pulses and 80 MHz. Emission spectra were collected through a 670 nm long-pass 
dichroic and photomultiplier tubes using filters of 380-490 nm to collect second 
harmonic generation, and 510-650 nm to collect fluorescein emission. 
To quantify cell density, images from normal controls were converted to 
binary images using Fiji with Sauvola local threshold.26 Binary images were then  
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Harvest 
Injury 
model 
Outcome 
measures 
Control group Injury group 
Image Gene Image Gene 
Image analysis      . 
•  Cell density 
•  Superficial zone cell density 
•  Cell death 
Gene expression analysis   
•  collagen type 2α1 
•  aggrecan  
•  cartilage-derived retinoic acid-sensitive  
•  serum amyloid A (SAA) 
•  matrix metalloproteinase 1, 13  
Figure 3.1. Schematic of methods. Biopsy punches (diameter=6 mm) were harvested 
(n=4 animals), divided equally into control and injured groups, and distributed to 
image or gene expression analysis. 
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processed with custom code in MATLAB (MathWorks, Natick, MA) to identify and  
quantify all chondrocyte profiles as a function of depth, using 50 µm binning. The 
relationship of cell density and depth for each sample was evaluated by fitting an 
exponential decay curve to the data points to characterize how the density of cells 
changed from the articular surface to the deep zone. The exponential decay curve’s 
decay rate length (“b”, where b=x in y=Ae-x/b) was quantified for each individual 
sample to give a numerical characteristic to describe the change in cell density with 
depth. A smaller value of decay rate length indicates a relatively dense region of cells 
at the surface and a significantly less dense region of cells in the middle and deep 
zones. A larger value of decay rate length indicates a more uniform distribution of 
cells among the surface, middle, and deep zones. This decay rate length was compared 
between joints.  
To quantify superficial zone cell density, cells from the superficial zone were 
identified in the above described images by selecting those cellular profiles that 
demonstrated an orientation within [-16°, 16°]. A histogram distribution of cellular 
profiles with 50 µm binning was calculated to determine the maximum density and 
depth at which maximal density occurred. Cell death was manually quantified in 
normal controls and injured samples using 50 µm binning. 
 
Gene expression analysis 
After 48 hours, explants for gene expression were rinsed in PBS, transferred to RLT 
lysis buffer (Qiagen, Germantown, MD), snap frozen in liquid nitrogen, and stored at -
80°C until processing. The explant and buffer were pulverized in liquid nitrogen using 
mortar and pestle. Then total RNA was isolated using the RNeasy Fibrous Tissues 
mini kit (Qiagen). Species-specific intron-spanning equine primers were used to 
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amplify cartilage genes collagen type 2α1 (COL2A1), aggrecan (AGG), cartilage-
derived retinoic acid-sensitive protein (CD-RAP), and inflammatory genes serum 
amyloid A (SAA), matrix metalloproteinase 1 (MMP-1), and MMP-13. Primers are 
listed in Table 3.1. Quantitative real-time RT-PCR (qPCR) was performed using the 
LightCycler® Fast Start DNA Master SYBR Green I and LightCycler ® Real-Time 
PCR System (Roche Diagnostics, Indianapolis, IN). Results were calculated using the 
efficiency corrected calculation method also known as the Roche Applied Sciences 
E(efficiency)-method: Normalized relative ratio = Et CT (target calibrator) – CT (target sample) / Er CT 
(reference calibrator) – CT (reference sample).27 Results were normalized to 18S. Expression in control 
samples are reported as normalized Cp, with higher normalized Cp values indicating 
higher gene expression. 
 
Statistical analysis 
Differences in cell density exponential decay, maximal cell density within the 
superficial zone, and depth of maximal density within the superficial zone were 
evaluated using an ANOVA, using SPSS version 21 (IBM Corporation, Armonk, 
NY). Significance of association between injury and percentage death of cells was 
evaluated using a t-test. Significance of association between the joint and death was 
evaluated using an ANOVA. Factors that were found to be significant were then 
evaluated together in a multivariate regression analysis to determine the effect of each 
factor while controlling for the effect of the other factors. The potential confounding 
effect of the depth was controlled for in the multivariate analysis by including it as a 
co-variate. Because data were clustered by animal, the potential random effect of 
horse was evaluated by adding the animal as a random effect factor in the analysis.  
Gene expression data were analyzed using a Kruskal Wallis non-parametric 
AOV with Dunn’s post-hoc test, using Prism 6 (GraphPad Software, Inc., La Jolla,  
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Primer name  Primer sequence (5’ → 3’) Primer source 
18S F GAT ACC GCA GCT AGG AAT DQ222453.1 18S R ATC TGT CAA TCC TGT CCG 
Aggrecan F CTT AGA GGA CAG AAA GCG AC 
Trumble et al 31 Aggrecan R ACT TTG GGC GGA AGA AGG 
CD-RAP F ATG CCC AAG CTG GCT GA EF679787 CD-RAP R CTT CGA TTT TGC CAG GTT TC 
Collagen type 2α1 F TCT GCA GAA TGG GCA GAG GTA TA NM_031163 Collagen type 2α1 R GAT AAT GTC ATC GCA GAG GAC ATT C 
MMP-1 F CAG TGC CTT CAG AAA CAC GA AF148882.1 
MMP-1 R GCT TCC CAG TCA CTT TCA GC 
MMP-13 F GCT GCC TAT GAG CAT CCT TC NM_00108180
4.1 MMP-13 R ACC TCC AGA CCT GGT TTC CT 
Serum amyloid A F CCT GGG CTG CTA AAG TCA TC AF240364.1 Serum amyloid A R AGG CCA TGA GGT CTG AAG TG 
 
Table 3.1. Primers used for real time quantitative RT-PCR. Primers were designed by 
the authors unless otherwise indicated. 
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CA). Control normalized gene expression and percent difference between control and  
injured were evaluated. All significance was evaluated at p<0.05. 
 
RESULTS 
Chondrocyte density and cell death 
The distribution of cells was fit to an exponential decay curve to determine if cell 
density varied in cartilage between different joints (Fig. 3.2, Table 3.2). The 
exponential decay rate length of cell density was not statistically different between 
joints (p=0.289). Maximal decay rate length was found in the FP joint (560 µm, 
SE=171 µm). Minimal decay rate length was found in the CA joint (234 µm, SE=70 
µm). The goodness of fit for the exponential model was evaluated by the correlation 
R2. The best fit was found in the MT joint (R2=0.78, SE=0.06). The least best fit was 
found in the SH joint (R2=0.57, SE=0.16). 
 Density of chondrocyte profiles within the superficial zone was different 
between joints, varying 0.20-2.54x10-3 cells/µm2 (Fig. 3.3, Table 3.3). The lowest 
superficial zone cell density was found in the FP, and the highest superficial zone cell 
density was found in MT in individual samples. MC had the highest mean density and 
was significantly higher than FP with the lowest density (p=0.001), PP (p=0.001), SH 
(p=0.003), EL (p=0.002), CA (p=0.005), and TA (p=0.033). MT had the second 
highest density and was significantly higher than FP (p=0.002), PP (p=0.004), SH 
(p=0.008), EL (p=0.007), and CA (p=0.016). The depth at which the maximal cell 
density occurred was not statistically different between joints (p=0.306, Fig. 3.3). Peak 
density occurred at 0-50 µm in 10% of samples, 50- 100 µm in 60%, 100-150 µm in 
27%, and 150-200 µm in 3% of samples. The overall mean depth of peak density was 
87 µm (SE=6 µm). 
 Cell death was compared between control and injury to determine if there was  
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Figure 3.2. Exponential decay rate length of cell density in cartilage. The thickest 
cartilage with the longest decay rate length was found in the patellofemoral joint (FP, 
mean=573 µm, SE=190 µm) and is shown with the thinnest cartilage with the shortest 
decay rate length that was found in the carpal joint (CA, mean=273 µm, SE=71 µm). 
Lengths of exponential decay rate between joints were not statistically different from 
each other (p=0.289, n=4). 
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Table 3.2. Chondrocyte density decay rate length with goodness of fit as R2. An 
exponential decay curve was fit to the data points of cell density as a function of 
depth. A smaller value has a shorter exponential decay of cell density than a larger 
value. Cartilage in the shoulder (SH), elbow (EL), carpal (CA), metacarpal (MC), 
proximal interphalangeal (PP), patellofemoral (FP), tarsal (TA), and metatarsal (MT) 
joints were evaluated. Decay rate lengths were not statistically different between 
joints (p=0.289, n=4). SE=standard error. 
 SH EL CA MC PP FP TA MT 
Decay length (µm) 573 281 273 345 420 560 236 266 
Decay length SE 190 50 71 201 167 170 24 36 
R2 0.56 0.75 0.60 0.71 0.67 0.61 0.77 0.78 
R2 SE 0.17 0.06 0.10 0.16 0.16 0.18 0.16 0.06 
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Figure 3.3. Distribution of superficial zone chondrocyte profiles. Peak superficial 
zone cell density was significantly higher in the metacarpus (MC) than the 
patellofemoral (FP, p=0.001), proximal interphalangeal (PP, p=0.001), shoulder 
(SH, p=0.003), elbow (EL, p=0.002), carpal (CA, p=0.005), and tarsal (TA, 
p=0.033) joints. Density in the metatarsus (MT) was significantly higher than FP 
(p=0.002), PP (p=0.004), SH (p=0.008), EL (p=0.007), and CA (p=0.016). 
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 SH EL CA MC PP FP TA MT 
Peak density 
(10-3 cells µm-2) 0.78*° 0.86*° 0.96*° 1.97 0.67*° 0.67*° 1.23* 1.8 
SE 0.11 0.14 0.22 0.19 0.12 0.12 0.30 0.38 
Table 3.3. Distribution of superficial zone chondrocytes. Peak superficial zone cell 
density was significantly higher in the metacarpus (MC) than the patellofemoral 
(FP, p=0.001), proximal interphalangeal (PP, p=0.001), shoulder (SH, p=0.003), 
elbow (EL, p=0.002), carpal (CA, p=0.005), and tarsal (TA, p=0.033) joints. 
Density in the metatarsus (MT) was significantly higher than FP (p=0.002), PP 
(p=0.004), SH (p=0.008), EL (p=0.007), and CA (p=0.016). * indicates p<0.05 
difference from MC; ° indicates p<0.05 difference from MT. 
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a difference in susceptibility to death between joints. Overall injured samples had 
significantly higher cell death (17.55%, SE=0.01) than non-injured samples (4.62%, 
SE=0.01, p<0.0001). Cell death was significantly different between joints (p=0.010). 
When analyzing the effect of injury between joints, the regression coefficient of depth 
from surface was found to be B=0.000, and the random effect of animal was not 
significant (p=0.704). Depth from surface and animal were therefore not used in the 
final multivariate regression analysis model. Injury and joint had significant effect on 
cell death (p<0.0001, Table 3.4). Cell death was decreased in controls by B=0.132 
(p<0.001) with SH used as the reference. Cell death was decreased in SH when 
compared with MT (p=0.002), TA (p<0.001), FP (p=0.032), and EL (p<0.001).  
 
Gene expression 
 Baseline gene expression was evaluated to determine if there were differences in 
chondrocyte expression between joints (Fig. 3.4). Baseline COL2A1 expression in 
controls was 12.4x higher in PP (median Cp=220.85, range 76.92-433.50) than in FP 
(Cp=17.85, 7.22-25.63, p=0.0114). Basal COL2A1 was 9.1x higher in PP than SH 
(Cp=24.35, 21.81-28.46, p=0.0460). Basal CD-RAP expression in controls was 23.5x 
higher in PP (Cp=360.15, 181.10-475.50) than in than FP (Cp=15.32, 12.05-41.80, 
p=0.0098). Basal CD-RAP was 21.7x higher in TA (Cp=331.85, 132.00-441.80) than 
FP (p=0.0202). No other significant differences in basal gene expression were found 
(AGG p=0.19, SAA p=0.05, MMP-1 p=0.29, MMP-13 p=0.22). 
 Changes in gene expression after injury were analyzed to evaluate differences 
in the gene response of chondrocytes between joints (Fig. 3.4). After injury, the 
change in CD-RAP expression increased 204% in FP (median change=79.10%, range 
36.46-393.94%) over MC (change=-55.46%, -71.41 - -45.94, p=0.0460). No 
significant differences in gene expression between joints were found for the other  
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Factor Regression coefficient SE p-value 
Control -0.132 0.01 <0.001 
Injury 0a   
PP 0.030 0.014 0.105 
MT 0.063 0.020 0.002 
TA 0.081 0.021 <0.001 
FP 0.038 0.018 0.032 
MC 0.031 0.020 0.134 
CA 0.024 0.022 0.264 
EL 0.079 0.019 <0.001 
SH 0a   
 
Table 3.4. A multivariate regression analysis was used to determine the of effect from 
injury (p<0.0001) and joint. The effect of the proximal interphalangeal (PP), 
metatarsal (MT), tarsal (TA), patellofemoral (FP), metacarpal (MC), carpal (CA), 
and elbow (EL) joints were compared to the effect of the shoulder (SH) joint (i.e., 
SH was the reference). SE=standard error; aparameter set to zero because it is 
redundant; p<0.05 considered significant (italicized). 
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Figure 3.4. (a) Baseline collagen type 2α1 (COL2A1) was significantly lower in the 
patellofemoral joint (FP) and shoulder (SH) than proximal interphalangeal joint (PP, 
**p=0.0114 and *p=0.0460, respectively). (b) Cartilage-derived retinoic acid-
sensitive protein (CD-RAP) was increased in PP and the tarsus (TA) over FP 
(**p=0.0098 and *p=0.0202, respectively). (c) After injury, CD-RAP was 
significantly increased in FP over the metacarpus (MC, *p=0.0460). Values above 
zero indicate increased gene expression, and values below zero indicate decreased 
gene expression. No statistical differences were found between the metatarsus (MT), 
carpus (CA), and elbow (EL). 
 74 
 
cartilage genes or inflammatory genes (COL2A1 p=0.05, AGG p=0.43, SAA p=0.10, 
MMP-1 p=0.63, MMP-13 p=0.22). 
 
DISCUSSION 
Comparison of baseline characteristics in normal cartilage and response to injury in 
eight different joints was performed to better understand the pathogenesis of PTOA. 
Between joints, differences were found in superficial zone cell density, cell death after 
injury, and gene expression. These results suggest that joints may have varying 
susceptibilities to the development of OA. 
 Cell density was quantified for each joint to determine which joints had 
differences in exponential decay rate length of cell density from superficial zone to 
deep zone. The cell density decay rate was not statistically different between joints. 
This suggests that distribution of cells within cartilage from articular surface to the 
deep zone was similar between joints, with most cells found in the superficial zone. 
Similar decay rate lengths between joints, with the peak cell density being found in the 
superficial zone, is consistent with previous biochemical data comparing FP, TA, and 
MT, where collagen and GAG concentrations were not significantly different.22 
Similar cellular distribution may result in similar concentrations of collagen and GAG 
concentrations.  
 Cell density within the superficial zone was calculated to compare if a zonal 
difference was present between joints. Cell density in the superficial zone was higher 
in both the MC and MT than in other joints. Differences previously found in response 
to stimuli5,6 and mechanical properties7,22 may result from the differences in the 
concentration of superficial zone cells. The peak density of cells in superficial zone 
was found to be near the similar depth of 87 µm from the articular surface in all joints. 
If the superficial zone extends to a similar depth in all joints, then the total volume of 
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middle and deep zones will consequently vary highly between joints. Because cell 
density decay rate is similar among joints, the volume of low cell density will be 
different in thin or thick cartilage, with thick cartilage having a larger region of low 
cell density. 
 Cell death after trauma was measured to help understand the differences in 
resiliency to injury between individuals and joints. The random effect of individual 
animal did not contribute significantly to cell death. While there was individual 
variability present, one individual was not consistently more resilient to injury than 
another. The association of different joints with cell death was significant, suggesting 
unique susceptibility to PTOA between joints. Cell death was increased in TA and FP 
over SH, and the distribution of OA in major joints is similarly higher in TA and FP 
than SH.2 Cell death was also relatively increased in EL over SH; however, EL has 
less incidence of OA than SH2 suggesting that cell death is likely only one of multiple 
factors in OA susceptibility. MT had a higher density of cells in the superficial zone 
than the other joints, yet had more cell death than SH. Superficial zone density may 
not be a factor in resilience to traumatic injury, and other factors not examined in the 
present study such as mechanical properties may contribute to these differences 
between joints. Images from injured samples were manually counted due to the high 
irregularity of collagen and fluorescence signals. Decreased emission in the impacted 
site made identification of cells, dead or alive, difficult and may have lead to a 
diminished area of damaged tissue being counted, creating a potential lower reported 
cell death. Yet, significance was found between control and injured despite this 
potential factor.  
 Gene expression was quantified to investigate potential differences in cellular 
activity between joints. Only CD-RAP and COL2A1 expression revealed significant 
differences. Expression of CD-RAP is associated with increased cell proliferation, and 
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is diminished in severe OA.28 CD-RAP was examined because its expression can 
change during the very early response to stimuli (<48 hours) and is down-regulated by 
IL-1β and TGF-β.30 Synthesis of collagen type II is important for maintaining the 
cartilage matrix.29 In the present study, CD-RAP and COL2A1 were expressed less in 
FP cartilage than in other joints. However, after injury, CD-RAP expression was 
significantly increased in FP compared to MC, yet FP superficial zone density is less 
than MC. MC and other joints with thin, chondrocyte-dense cartilage may respond 
differently than thicker joints. This might also suggest that middle and deep zone cells 
have a different role in gene expression and matrix maintenance than superficial zone 
cells. An inverse relationship may exist between cartilage zones and gene expression 
and would need to be further studied for implications in PTOA development. 
 Overall, differences were found in superficial zone cell densities, cell death, 
and gene expression between joints. Superficial zone chondrocytes were most dense in 
MT and MC, implying that cells in this zone may be different between joints. Cell 
death was relatively increased in MT, TA, FP, and EL over SH. Basal CD-RAP and 
COL2A1 were lower in FP, yet after injury, CD-RAP expression increased 
significantly more in FP. These differences between joints suggest that findings from a 
single joint cannot be extrapolated to other joints. The baseline characteristics of 
chondrocytes in different joints may have an effect on how cartilage responds 
differently to injury between joints. This may result in different pathologies of PTOA 
between joints and subsequently in joint-specific future targets for PTOA treatment. 
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ABSTRACT 
Post-traumatic osteoarthritis (PTOA) affects many adults and may not be diagnosed 
for years after injury. Oxygen has varying roles in supporting and diminishing 
cartilage function in normal and injured cartilage. In the present study, the effect of 
intermittent oxygen exposure on chondrocyte viability after injury was evaluated. 
Bovine cartilage was injured, recovered for 60 minutes, and cultured for 3 days with 
the following conditions: 5% O2 — 5% O2 — 5% O2 (static normoxic), 5% O2 — 21% 
O2 — 5% O2 (hyperoxic recovery), 21% O2 — 5% O2 — 5% O2 (hyperoxic injury), 
and 21% O2 — 21% O2 — 21% O2 (static hyperoxic). Uninjured controls were treated 
with the same conditions. Cell viability was quantified at the end of the culture 
duration. Viability in controls was highest in the static normoxic condition 
(mean=83.6%, SE=3.7%) and lowest in the static hyperoxic condition (mean=73.5%, 
SE=6.7%). After injury, viability was highest in hyperoxic recovery (mean=60.2%, 
SE=5.9%) and lowest in static normoxic (mean=51.1%, SE=6.4%). Hyperoxic 
recovery samples (5—21—5 and 21—21—21) had significantly less cell death after 
injury (mean= -23.9%, SE=3.8%) than normoxic recovery samples (5—5—5 and 
21—5—5, mean= -36.7%, SE=5.3%, p=0.049). This study implies short term, high 
oxygen exposure has beneficial effects after injury and could have a role in PTOA 
therapeutic treatment. 
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INTRODUCTION 
Osteoarthritis (OA) is a degenerative disease affecting a large portion of the American 
and world population.1-3 OA is a complex disease that has many contributing factors.1,4 
It has been well established that mechanical trauma can result in cell death,5,6 which 
leads to post-traumatic OA. There is a growing awareness of the need to investigate 
PTOA.7 It is estimated that PTOA contributes to 12% of all OA cases.3 It is clinically 
difficult to diagnose PTOA in origin because injury can occur years to decades before 
clinical symptoms of OA become apparent.8 
 The role of oxygen in cartilage health could have implications in the 
development of PTOA. Cartilage is avascular and, as a result, has limited oxygen 
supply. It is estimated that oxygen tension in normal cartilage is about 6% near the 
articular surface, with decreasing oxygen with depth to as low as 1% oxygen.9 In OA, 
oxygen tension is increased in some individuals, with synovial fluid reported to have 
as high as 9% to 10% O2.10,11 Increasing oxygen tension negatively affects cartilage in 
vivo. In adult porcine cartilage, nitric oxide production is lowest when samples are 
cultured at 1% O2 compared to 5% or atmospheric 20% O2.12 In human OA cartilage, 
both nitric oxide production and glycosaminoglycan loss from the matrix are increased 
at 21% O2 compared to 5% O2.13 Oxygen tension also affects the ability of 
chondrocytes to respond to cytokines. Nitric oxide production is highest in adult 
porcine cartilage treated with IL-1α and cultured at 20% O2 compared with 1% O2.14 
This suggests that higher oxygen tension leads to increased inflammatory mediators 
which could increase the risk of developing OA. When cartilage is subjected to 
mechanical loading, the effect of oxygen on the production of inflammatory mediators 
echoes that which is found with cytokine treatment and oxygen exposure. Nitric oxide 
production in adult porcine cartilage loaded with 0.05 MPa at 0.5 Hz for 24 hours is 
lower after culture at 1% O2 than at 5% or 20% O2.12 Overnight pre-treatment of adult 
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bovine cartilage with super oxide dismutase results in a decreased number of apoptotic 
cells in four days following injury of 50% strain and 25-29 MPa peak stress.15 
Similarly, N-acetyl cysteine treatment within four hours of injury reduces cell death in 
mature bovine cartilage.16 This suggests that increased oxidant scavengers present 
during injury leads to better long term outcome. This also suggests that higher oxygen 
tension during injury, or cracking of cartilage leading to higher oxygen exposure in the 
deeper layers, results in worse outcome after injury and contributes to the development 
of PTOA. 
 While many studies report that increased oxygen is detrimental to cartilage, 
other studies have found it to have beneficial effects. Proteoglycan synthesis in 
neonatal bovine cartilage is highest at 21% O2 when compared to oxygen tensions 
above and below 21%, ranging 3-60% O2.17 ATP production is higher when adult 
porcine cartilage is cultured at 20% O2 than 1% O2.14 Exposure to oxidant treatment 
can also lead to resilience of chondrocytes to injury. Forty-eight hour pre-treatment 
with tert-butyl hydrogen peroxide (TBHP), a potent oxidant, resulted in decreased cell 
death in juvenile porcine cartilage after 5 MPa loading at 1 Hz for 30 minutes 
compared to non-TBHP-treated controls. Glycosaminoglycan loss from explants to 
media was also minimized with the use of TBHP pre-treatment. These beneficial 
effects of TBHP were observed to a certain point—after a maximal concentration of 
TBHP was reached, increased GAG loss was observed.18 These studies suggest that 
oxygen exposure may be beneficial in limited duration and concentration.  
The relationship between oxygen and cartilage health is complex. The same 
work that reported 10% O2 tension in synovial fluid in naturally-occurring arthritic 
joints, also reported oxygen tensions as low as 1% O2.11 Previous work has shown that 
chondrocytes grown in alginate at <0.01%, 5%, 10%, or 20% O2 have decreased total 
abundance of mRNA at <0.01% O2. However, cell proliferation was not affected by 
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hypoxia.19 It appears that normoxic and hyperoxic conditions both support cartilage 
health, while hypoxic conditions do not. Although there is not an immediate and direct 
link between oxygen tension and development or treatment of OA or PTOA, 
intermittent, strategically applied oxygen exposure could improve cartilage resilience 
to trauma. 
 The goal of this study was to evaluate the effect of normoxic (5% O2) and 
hyperoxic (21% O2) conditions during injurious compression, short term recovery 
after injury, and culture after injury. The hypothesis of this study was that normoxic 
levels of oxygen during injury, recovery, or culture would lead to increased cell 
viability and that hyperoxic levels would decrease viability. The results from this 
study will help to improve the understanding of the pathogenesis of PTOA and help to 
determine the optimal use of increased or reduced oxygen treatment after traumatic 
injury. 
 
METHODS 
Tissue collection and injury model 
Full-thickness cartilage explants (diameter=6 mm) were harvested from bovine, left, 
distal third and fourth metatarsus. Animals (ages 12-36 months, n=9) were euthanized 
for reasons unrelated to this study under the guidelines and approval of the 
Institutional Animal Care and Use Committee. Explants for control or injury were 
collected from the same condyle (n=4 pairs per animal; n=8 animals). The condyle 
from each control and injury pair was randomized for subsequent treatment conditions 
(see Fig. 4.1 for methods schematic). Cartilage was grossly evaluated and scored using 
the International Cartilage Repair Society Clinical Cartilage Injury Evaluation system 
- 2000.20, 21 Only samples receiving a “0” were used for the study. 
After explants were harvested, they were immediately submerged into a  
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Injury Recover 1 h Culture 3 d 
5% 5% 5% 
Static normoxic 
5-5-5 
21% 5% 5% 
Hyperoxic injury 
21-5-5 
5% 21% 5% 
Hyperoxic recovery 
5-21-5 
21% 21% 21% 
Static hyperoxic 
21-21-21 
(a) 
(b) (c) 
Figure 4.1. Schematic of methods. (a) Explants were harvested. Corresponding 
control and injured explants were collected from the same condyle, with n=4 pairs 
of explants, as shown in a, harvested from each animal (n=8 animals). (b) Explants 
were injured within equilibrated media. (c) Each pair of explants was randomized 
to one of four oxygen conditions. 
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custom-designed specimen chamber containing media that had been equilibrated 
overnight to either 5% O2 or atmospheric (21%) O2. Media consisted of phenol red-
free MEM with 25 mM Hepes, 2 mM L-glutamine, 50 µg/ml ascorbic acid, 30 µg/ml 
α-ketoglutaric acid, 10% FBS, 100 IU/ml penicillin, and 100 µg/ml streptomycin. 
Explants and specimen chambers were mounted on an EnduraTEC ELF3200 
mechanical test frame (EnduraTec, Minnetonka, MN). Explants were loaded with 30 
MPa22 within 1 second. Explants remained in the same 5% O2 or atmospheric O2 
equilibrated media, or were transferred to the opposite equilibrated media, and were 
recovered for 60 minutes at 37°C. After the recovery period, explants were transferred 
to fresh, pre-equilibrated media of the same 5% O2 or atmospheric O2 or were 
transferred to the opposite equilibrated media, and incubated for 3 days.  
 The equilibration of O2 at impact, recovery (1 hour), and culture (3 days) were 
one of the following four O2 tension conditions: 5% — 5% — 5% (static normoxic), 
5% — 21% — 5% (hyperoxic recovery), 21% — 5% — 5% (hyperoxic injury), and 
21% — 21% — 21% (static hyperoxic). 
 
Confocal imaging 
After 3 days in culture, explants were removed from the media and cut in half to 
image the full depth of cartilage in cross section. Explant halves were incubated in 4 
µM calcein AM (LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells, 
Invitrogen, Molecular Probes, Eugene, OR) for 15 minutes at 37°C. Then 2 µM 
ethidium homodimer-1 (LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian 
cells, Invitrogen) was added, and explants were incubated in calcein AM and ethidium 
homodimer-1 solution for an additional 15 minutes. Samples were rinsed in PBS and 
imaged with confocal. 
Imaging was performed on a Zeiss LSM510 Meta Axiovert 200 inverted 
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confocal microscope (Zeiss, Thornwood, NY) with 1.75 µm pixel-1 resolution. Calcein 
AM and ethidium homodimer-1 excitation and emission collection were performed 
using the recommended wavelengths from the manufacturer. Excitation and emission 
for each dye were collected in sequential steps, and bleed through into opposing 
channels was confirmed prior to data acquisition. A tiled 5-step z-scan of x=3.6 mm 
(axis parallel to articular surface), y=1.8 mm (axis perpendicular to articular surface), 
and z=50 µm (z-stack of 10 µm intervals) was acquired to encompass normal tissue 
outside the edge of injury and the full depth of injury from articular surface to deep 
zone. 
 
Image and viability data analysis 
Images from calcein AM and ethidium homodimer-1 were analyzed separately. First, 
multiple channel, z-stack images were split in Fiji. Resultant images were processed in 
custom code created in MATLAB R2013a (MathWorks, Natick, MA), which was 
similar to MATLAB-code “Identifying Round Objects,” where chondrocytes were 
identified as objects. Each calcein AM or ethidium homodimer-1 image was first 
thresholded to a black and white image (graythresh, im2bw). A smoothing function 
was applied to objects within an image (bwareaopen), after which any holes in an 
image were filled (imfill). Objects were further smoothed (imerode) and then dilated 
(imdilate). Object boundaries were identified (bwboundaries) so that area and 
perimeter properties could be determined (regionprops). If the area and perimeter were 
within given threshold values, objects were counted as chondrocytes. Due to the 
presence of clustered cells, area and perimeter threshold values were used to 
accommodate single, double, and triple clustered cells. Object counts of chondrocytes 
were recorded separately for all calcein AM and ethidium homodimer-1 images. 
Collecting confocal images of a uniform flat plane was not feasible for all samples, 
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particularly with injured explant samples that had noticeable cracks within the matrix, 
so cell counts from all z-stack images within one sample were combined and treated as 
a single viability measure for subsequent statistical analysis. 
 
Statistical analysis 
Viability was calculated for each treatment condition. Differences in viability between 
O2 tension conditions in uninjured controls were compared using a Kruskal Wallis test 
in SPSS version 21 (IBM Corporation, Armonk, NY) due to the non-parametric 
distribution of viability data. To confirm a significant effect of injury on viability, a 
Mann Whitney test was used to compare the overall mean viability in control to 
injured explants. Then, the percent difference in viability between control and injured 
for each corresponding oxygen condition was calculated. To determine the effect of 
the four oxygen conditions on viability after injury, the percent difference of viability 
in control and injured explants between oxygen conditions was compared using a 
Kruskal Wallis test. To evaluate the effect of O2 tension during recovery on viability 
after injury, samples recovered at hyperoxia (static hyperoxic and hyperoxic recovery 
conditions) were grouped together, and samples recovered at normoxia (static 
normoxic and hyperoxic injury conditions) were grouped together. A Mann Whitney 
test performed on the percent difference of control and injured viability to compare the 
two recovery O2 conditions. A p<0.05 was considered significant. 
 
RESULTS 
Confocal imaging 
Images were acquired with confocal microscopy to demonstrate changes in viability 
between oxygen conditions and after injury. Live and dead cells were easily identified 
in both control and injured cartilage explants (Fig. 4.2). In injured samples, the site of  
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Figure 4.2. Images of control and injured cartilage in the hyperoxic recovery 
condition group, where the cartilage was injured at 5%, recovered 60 minutes at 
21%, and cultured 3 days at 5% O2. Control cartilage typically had high viability, 
as indicated by live cell staining with calcein AM (green) and dead cell staining 
with ethidium homodimer-1 (red). Injured samples had decreased viability. 
!
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injury was easily identified in all samples. Most samples had noticeable areas of 
matrix surface irregularities that could be identified with the unaided eye. When 
imaging with confocal, cracks were identified that lacked any stained cells, dead or 
alive, and were noted in most samples. 
 
Effect of oxygen tension on control viability  
In uninjured, control samples, cell viability was highest in the static normoxic 
condition  (Fig. 4.3, mean=83.6%, SE=3.7%). With oxygen exposure, viability 
decreased in uninjured control samples. Viability was decreased by 12.1% in the static 
hyperoxic condition (mean=73.5%, SE=6.7%) when compared to static normoxic. 
However, no statistical significance between groups was found (p=0.311). 
 
Effect of oxygen tension after injury 
The effect of injury on viability was confirmed to be significant prior to performing 
subsequent statistical analysis between oxygen treatment groups. After injury, viability 
in all groups was reduced by 31.4% compared to uninjured controls (p<0.0001). 
Differences between oxygen treatment conditions were subsequently evaluated. 
 The lowest viability after injury was found in the static normoxic condition 
(Fig. 4.3, mean=51.1%, SE=6.4%), followed by hyperoxic injury condition 
(mean=52.7%, SE=6.4%). Both static normoxic and hyperoxic injury conditions were 
recovered at 5% O2. The highest viability after injury was found to be in the hyperoxic 
recovery condition (mean=60.3%, SE=5.9%), followed by the static hyperoxic 
condition (mean=56.8%, SE=4.5%). Both hyperoxic recovery and static hyperoxic 
conditions were recovered at 21% O2.  
 To determine the effect of oxygen conditions after injury, the percent 
difference between the paired control and injured samples was quantified and  
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Figure 4.3. Chondrocyte viability with normoxic and hyperoxic treatment. Viability in 
control samples was highest in static normoxic (5-5-5), where the cartilage was 
cultured at 5% O2 for the entire experiment, and lowest in static hyperoxic (21-21-
21), where samples were at 21% O2 for the experiment. After injury, viability was 
highest in hyperoxic recovery (5-21-5), where samples were injured at 5% O2, 
recovered for 60 minutest at 21%, and cultured for 3 days at 21%, and was lowest 
at the normoxic condition. No significant differences were found between groups. 
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evaluated. The largest decrease in viability after injury was found in the static 
normoxic condition (Fig 4.4, mean=-38.2%, SE=7.5%). The next largest decrease was 
in the hyperoxic injury condition (mean=-35.2%, SE=7.9%). The smallest change in 
viability after injury was found in the static hyperoxic condition (mean=-20.9%, 
SE=5.0%), followed by the hyperoxic recovery condition (mean=-26.5%, SE=5.8%). 
No significant differences were found when comparing the four conditions to each 
other (p=0.232). To compare the effect of normoxia and hyperoxia recovery, samples 
recovered at 5% O2 were clustered together (mean=-36.7%, SE=5.3%) and those 
recovered at 21% O2 were clustered together (mean=-23.9%, SE=3.8%). Those that 
were recovered at normoxia had significantly decreased relative viability after injury 
compared to those recovered at hyperoxia (p=0.049). 
 
DISCUSSION 
This study suggests that oxygen tension affects chondrocyte viability. Hyperoxic 
treatment of 21% O2 delivered immediately after injury could reduce long term cell 
death. This finding implies that hyperoxic treatment has a therapeutic role for injury 
treatment, including hyperbaric or high oxygen treatments. 
 The results of this present study found the highest cell viability in uninjured, 
control samples exposed to 5% O2. These results support the work of previous studies 
that have found 5% O2 to be optimal for maintaining in vivo cartilage characteristics 
during in vitro experiments, including matrix permeability, mechanical properties,23 
and glycosaminoglycan concentration.13 The oxygen tension used in the normoxic 
condition in the present study most closely represents the oxygen tension found intra-
articularly, which is estimated to be 1-6%.9 Many studies show that cartilage 
inflammatory mediators12,14 and apoptosis15 are decreased with 5% O2 or decreased 
oxidant exposure, much work in literature has been and is still consistently performed  
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Figure 4.4. Hyperoxic treatment minimized chondrocyte death. The percent difference 
between control and corresponding injured sample was calculated and compared to 
determine the overall effect of oxygen on injury. The hyperoxic recovery condition 
(5-21-5), where samples were injured at 5% O2, recovered at 21%, and cultured at 
5%, had the smallest relative decrease in viability. The static hyperoxic condition 
(21-21-21), where samples stayed at 21% for the experiment, and the hyperoxic 
injury condition (21-5-5), where samples were injured at 21% and then recovered 
and cultured at 5%, had decreasing relative viability, respectively. The static 
normoxic condition (5-5-5), where samples remained at 5% O2 throughout the 
experiment, had the largest relative decrease in viability. Cartilage recovered at 
hyperoxia (21-21-21, 5-21-5) had significantly less chondrocyte death after injury 
than those recovered at normoxia (5-5-5, 21-5-5).  
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at atmospheric 20-21% oxygen. The work in the present study supports these 
findings—maintaining normal cartilage at atmospheric oxygen results in suboptimal 
chondrocyte viability. Baseline data collected at 20-21% O2 is skewed toward 
increased cell death as shown in the present study, apoptosis,15 and inflammatory 
mediators.12,14 
 Chondrocyte viability was highest after injury if immediately treated with 
hyperoxic 21% O2 tension. When compared to uninjured controls with the same 
oxygen treatment, static hyperoxic and hyperoxic recovery conditions had improved 
viability over static normoxic and hyperoxic injury conditions. This suggests that 
allowing injured cartilage to recover in hyperoxic conditions reduces cell death 
associated with trauma. This may result from the increased synthetic activity of 
cartilage at high oxygen tension.14,17,19 These benefits were limited to injured 
cartilage—there was a slight but non-significant decrease in viability found in 
uninjured cartilage maintained at static hyperoxia. Other studies report limitations to 
the beneficial effects of hyperoxia. In adult bovine cartilage cultured at 6-91% O2, 
samples in oxygen tensions of 24-91% had increased glycosaminoglycan synthesis 
after 24 hours. However, after this initial time period at high oxygen tension, 
glycosaminoglycan synthesis decreased. Samples cultured at 6-10% O2 had relatively 
steady glycosaminoglycan synthesis.24 The optimal time of exposure to oxygen still 
needs to be considered, but the present work combined with previous studies suggests 
that exposure to high oxygen tension supports cartilage homeostasis. 
 Translating an in vitro hyperoxic environment to a patient-accessible, in vivo 
hyperoxic treatment will be challenging. The most feasible means for increasing 
oxygen within the joint are by increasing total body oxygen through oxygen inhalation 
or through increased or modified hemoglobin. Administering high oxygen 
concentration at hyperbaric pressures can lead to increased oxygen within plasma, 
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which results in increased synovial fluid oxygen. Hyperbaric oxygen treatment 
increases oxygen within the joint by over two-fold.25 Hyperbaric treatment also 
improves cartilage repair. There is improved healing of full thickness cartilage defects 
within knees of rabbits given 100% O2 at 2.5 atm for 2 hours per day for 5 days 
compared to those not receiving hyperbaric treatment. Improved healing after 
hyperbaric treatment included decreased chondrocyte apoptosis, increased keratin 
sulfate synthesis, increased thickness of repair cartilage, and increased number of cells 
in repair cartilage.25 Delivering hyperbaric treatment immediately after injury, such as 
during an athletic event, is not widely available. Hyperbaric treatment requires special 
equipment, particularly a pressurized chamber. Simple administration of high oxygen 
at atmospheric pressure will not yield the same increased plasma oxygen or result in 
the same beneficial healing effects. An alternative approach for increasing oxygen 
within a joint may be with drug delivery, such as using polymerized hemoglobin to 
increase total hemoglobin-bound oxygen within the body or an allosteric modifier of 
hemoglobin to deliver more oxygen to tissue. Extensive testing is needed for general 
safety and efficacy of these types of drugs for cartilage injury, and there is high risk 
for abuse with these drugs, particularly with performance enhancement in the athletic 
field. However, hyperoxic treatment is promising, and optimal oxygen tension and 
duration of exposure needs to be determined with future work.   
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CHAPTER 5 
DISCUSSION, FUTURE DIRECTION, CONCLUSION 
 
Discussion 
The research presented in this dissertation was performed to improve the 
understanding of early cartilage injury using high resolution imaging. The introduction 
justifies the necessity of high resolution imaging of cartilage and reveals the utility of 
multiphoton microscopy (MPM) over other in vivo imaging techniques. Chapter 2 
evaluates the use of MPM for detecting cartilage injury. Chapter 3 characterizes the 
unique susceptibility of cartilage from different joints to injury. Chapter 4 examines 
the potential role of increased oxygen tension as an approach to minimize cell death 
after injury. 
Chapter 2 validates the use of high resolution MPM for identifying cartilage 
injury as a technique that could be adapted for clinical use to further our understanding 
of post traumatic osteoarthritis (PTOA). Because there is no current in vivo method of 
identifying subtle, early cartilage injury, longitudinal studies of PTOA development 
are limited. Current studies typically use magnetic resonance imaging (MRI) or 
computed tomography (CT), both of which have inferior resolution capacities to 
MPM, to monitor the progression of PTOA after cartilage injury. The presence of a 
small (<2 µm) crack or a cluster of dead cells in a region of diseased cartilage cannot 
be monitored with MRI or CT until after significant structural damage (>0.5 mm) has 
developed. To circumvent this issue in current studies, typically, multiple groups of 
animals are sacrificed at different time points to collect cartilage so that high 
resolution imaging of histological sections can be performed. Use of different animals 
to study disease progression is not an optimal approach for the study of PTOA. 
Unique patterns of damage between animals that resulted from the same injury were 
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identified in Chapter 2. This suggests that if using multiple groups of animals to study 
times points, different damage patterns between animals may affect the findings or 
lead to high variability. In addition, performing longitudinal studies where in vivo 
microscopy can be performed in place of terminal, histologic imaging would lead to 
more accurate findings about the progression of PTOA. 
Chapters 3 and 4 imply the need for new treatment paradigms. In Chapter 3, 
MPM was used to characterize the differences in response to injury between joints and 
suggested that different joints have varying responses to injury with respect to matrix 
damage and cell death. This is supported by the clinical observation in human and 
animal patients that different joints have unique susceptibilities to the development of 
PTOA. This suggests that the application of a universal cartilage treatment after injury 
is not optimal, and joint specific treatments following injury should be considered. 
Chapter 4 evaluated the effect of oxygen tension on cartilage injury and unexpectedly 
found that hyperoxic exposure is protective from chondrocyte death if delivered for 
short duration immediately after injury. Overall, the work in this dissertation 
established the application of MPM in ex vivo studies for providing a means of 
collecting quantifiable, high resolution images and the potential for translating this 
technique to clinical use. 
 
Future direction 
Can MPM be adapted for clinical, diagnostic use? 
MPM resolves focal cartilage injury and has potential for clinical application. 
The traumatic loading used in Chapters 2-4 caused cartilage damage that was <0.5 mm 
in depth, which is below the resolution of MRI and CT. MPM has the potential to be 
adapted to for arthroscopic application and is being evaluated for clinical use in other 
fields.1-4 If a surgeon recommends surgery to a patient based on his/her MRI and/or 
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CT, during the subsequent arthroscopic procedure, the precise border of a lesion could 
be located with arthroscopic MPM, “healthy-appearing” regions neighboring degraded 
regions could be further evaluated, and “healthy-appearing” cartilage in a joint that 
had other damage, such as a ligament tear, could be further evaluated microscopically. 
Longitudinal evaluation could be performed, both clinically and in in vivo studies. 
Longitudinal studies would allow further characterization of PTOA progression and 
development of new treatment algorithms—either drug or rehabilitation in design.  
When applied arthroscopically, cartilage damage could be clinically 
characterized by identifying regions with dead cells (sodium fluorescein), disrupted 
matrix (second harmonic generation (SHG) and autofluorescence), and optical 
biomarkers (autofluorescence). The work in Chapter 2 demonstrated the novel use of 
sodium fluorescein as a dead cell dye. Sodium fluorescein is already FDA approved. 
Use of this dye would allow the surgeon to identify and quantify region(s) of dead 
cells, which would subsequently be removed by debridement. This will provide a 
significantly refined method of cartilage evaluation compared to the current clinical 
standard of subjective determination of healthy/diseased cartilage based on palpation 
of the cartilage surface with a metal probe. Sodium fluorescein would also add another 
tool for diagnostic and research protocols in early PTOA. Longitudinal studies of 
sodium fluorescein stained regions would determine if cell death truly leads to 
widespread PTOA and/or if treatments such as hyperoxic, antioxidant, anti-
inflammatory, cryotherapy, or rehabilitation immediately after injury could preserve 
dead cell regions from progressing into diseased tissue and PTOA. Regions with 
damaged extracellular matrix would be easily identified with SHG and elastin 
autofluorescence. Longitudinal studies of matrix damage will determine the minimal 
threshold of damage that leads to PTOA—does a 2 µm crack become larger with time 
and lead to a widespread area of cartilage matrix with compromised mechanical 
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integrity? Autofluorescent structures are visible in grossly normal cartilage that 
neighbors diseased tissue (data not shown). These autofluorescent structures vary in 
emission wavelength and location (extracellular, intracellular). These structures may 
serve as optical biomarkers that could be used for future diagnostic application, 
whether directly with MPM or with adaptation to biochemical assays. 
The safety and applicability of MPM for clinical use needs to be further 
evaluated. MPM utilizes pulsed near infrared (NIR) light during imaging. NIR light is 
generally considered to be biologically safe. However, the far ends of the NIR range 
(<800 nm and >1400 nm) have harmful effects. Lower energy, longer wavelength NIR 
(>1400 nm) causes excitation of water. Imaging with excitation wavelengths >1400 
nm can heat the water in tissue and cause thermal damage. Two-photon excitation 
(TPE) of higher energy, shorter wavelength NIR (<800 nm) can elicit ultraviolet (UV) 
excitation. Because TPE essentially causes the same excitation as a single photon at 
half the wavelength, using <800 nm photons with MPM can cause <400 nm excitation 
and DNA damage. For clinical use, MPM would need to utilize >800 nm to avoid TPE 
induced UV excitation. NIR excitation >800 nm, however, would not be able to avoid 
all UV excitation processes because, although low in occurrence, three photon 
excitation (equivalent to a single photon at a third of the source wavelength) can also 
elicit UV excitation. Safety testing to examine DNA damage with MPM 800-1400 nm 
will be needed before clinical application.5 Ex vivo studies, on the other hand, might 
be better served using <800 nm excitation because second harmonic generation and 
autofluorescence is stronger at <800 nm wavelengths. 
 The clinical application of MPM will be challenging due to its field of view 
and need of relative stability between the imaging surface and MPM objective. The 
trade-off for providing submicron resolution is a limited field of view (<0.5 mm x 
<0.5 mm). This is a disadvantage in a clinical setting because the time needed to 
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evaluate the joint surface would likely exceed 30 minutes. Furthermore, current 
objective lens designed for in vivo use, such as the Olympus Microprobe Objectives, 
have a working distance of 0.2 mm. This means that the objective needs to be 
positioned in a parallel plane to and 0.2 mm from the surface of the tissue. This 
precise positioning could be difficult to obtain during an arthroscopic procedure. 
Laboratory MPM imaging utilizes low vibration tables. A low vibration adaptation 
would need to be made for clinical use, such as a locking armature, because the MPM 
instrumentation could not be hand-held during imaging. 
  
Should future cartilage research continued to be performed in one joint? 
 The work in Chapter 4 suggests that each joint has different cell distribution 
and gene expression levels that affect susceptibility to trauma This suggests that 
findings from studies examining a single joint should not be applied to other joints: 
studies evaluating chondrocyte death in the distal metatarsus (increased cell death) 
should not be assumed true for the proximal humerus (decreased death). Multi-joint 
studies may be more ideal; however, the feasibility of performing these studies is not 
always possible, particularly in human studies that rely on cartilage collected during 
joint replacement procedures. Therefore, determining the most representative cartilage 
for single-joint studies may be a future step. Results in Chapter 4 further suggest thin 
cartilage may behave differently than thicker cartilage, so single-joint studies may 
ultimately be limited in the applicability to future clinical work. Overall, different 
joints might have different pathologies of PTOA, and future work can help to 
determine the differences in disease progression, which may lead to joint-specific OA 
treatments. 
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Could oxygen play a role in future PTOA treatment? 
 In Chapter 4, hyperoxic treatment was able to minimize cell death after injury. 
Short duration hyperoxic treatment appears beneficial not only for injured cartilage—
previous work has shown that 24 hours at hyperoxic conditions increases 
glycosaminoglycan synthesis.6 These in vitro findings can be adapted to in vivo 
application. Hyperbaric treatment can increase oxygen concentration in a joint by two-
fold and increase keratin sulfate synthesis.7 Combined, these findings suggest that 
exposure to high concentrations of oxygen for short time periods of time could help 
minimize detrimental effects of injury and may have a potential role in mitigating the 
progression of PTOA. In order for this to be an effective treatment, hyperbaric or 
hyperoxic treatment would need to be delivered immediately after injury. This short 
treatment window suggests that a physician appointment within the following day or 
two is not sufficient. Alternative methods of delivering hyperoxic treatment to joints 
will need to be developed. Determining the optimal delivery method to patients, 
oxygen concentration, and duration will need to be evaluated in future work for this 
potential therapeutic treatment. 
 
Conclusion 
The development of PTOA is variable and individualized, both in joints and individual 
animals and people. Being able to longitudinally evaluate cartilage early with MPM 
will facilitate the development of early intervening treatments to slow the progression 
of disease. The etiology of PTOA is diverse, and oxygen may play a role during the 
very early developments of cartilage damage. While long term exposure to oxygen 
may exacerbate cell death, it appears the hyperoxic exposure may have a potential 
application as a therapeutic treatment for cartilage after injury. By understanding the 
differences between joints and injuries in future studies and being able to identify 
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subtle injuries in the acute phase with high resolution imaging, the mechanisms of 
PTOA can be further resolved and new treatments developed. 
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